vigabatrin carbamazepine use seizures absence
vigabatrin carbamazepine use seizures
carbamazepine use seizures absence
carbamazepine use seizures
vigabatrin Carbamazepine contraindicated seizures absence
vigabatrin Carbamazepine contraindicated seizures
Carbamazepine contraindicated seizures absence
Carbamazepine contraindicated seizures
carbamazepine two jerks myoclonic
carbamazepine two jerks
carbamazepine withdrawal resolved jerks myoclonic
carbamazepine withdrawal resolved jerks
5 infusion occurred reaction consisting edema angioneurotic
5 infusion occurred reaction consisting edema
fluorouracil occurred reaction consisting edema angioneurotic
fluorouracil occurred reaction consisting edema
testosterone screened basis desire low
testosterone screened basis desire sexual
testosterone screened basis desire
testosterone gynecomastia desire low
testosterone gynecomastia desire sexual
testosterone gynecomastia desire
testosterone Determining cases desire low
testosterone Determining cases desire sexual
testosterone Determining cases desire
testosterone missed Determining cases desire low
testosterone missed Determining cases desire sexual
testosterone missed Determining cases desire
testosterone determined cases desire low
testosterone determined cases desire sexual
testosterone determined cases desire
testosterone desire low
testosterone desire sexual
testosterone desire
LiCl contained diet consuming rats developed polyuria
Lidocaine induced asystole cardiac
Lidocaine induced asystole
ouabain administered tachycardias ventricular
ouabain administered tachycardias
cocaine kindled steroids efficacy seizures
cocaine engendered administration kindling seizure
cocaine administration kindling seizure
cocaine development seizures
cocaine administration induced seizures
Prazosin induced incontinence stress
Prazosin induced incontinence
prazosin due incontinence stress
prazosin due incontinence
prazosin taking change incontinence Patients present stress
prazosin taking change incontinence
Desipramine induced delirium
Desipramine treated patient developed delirium
streptozotocin vincristine induced hyperalgesia
streptozotocin vincristine induced hyperalgesia model chemotherapy diabetic
streptozotocin vincristine induced hyperalgesia model neuropathy
vincristine induced hyperalgesia
vincristine produced hyperalgesia
streptozotocin induced hyperalgesia
streptozotocin participates seemed bradykinin hyperalgesia
vincristine seemed participates streptozotocin induced hyperalgesia
vincristine seemed bradykinin hyperalgesia
Rizatriptan superior ergotamine proportions patients nausea
rizatriptan caffeine events dizziness 6 nausea
rizatriptan caffeine events dizziness
rifampin therapy associated glomerulonephritis
rifampin treated patient glomerulonephritis
rifampin regimen 10 underwent discovered developed signs failure renal
rifampin regimen 10 underwent discovered developed signs failure
rifampin treated patient documents occurrence glomerulonephritis
rifampin treated patient documents occurrence glomerulonephritis crescents glomerulonephritis
Antidepressant mania
Antidepressant mania patients bipolar
antidepressants associated mania
antidepressants associated mania switching risks Concerns continue interfere establishment paradigm depression bipolar
antidepressants associated mania switching risks Concerns continue interfere establishment paradigm depression
antidepressant therapy type diagnosis structured Patients experienced compared switch manic
antidepressant therapy type diagnosis structured Patients experienced compared switch manic hypomanic
antidepressant therapy type diagnosis II vs DSM
antidepressant therapy type diagnosis II vs IV
antidepressant therapy type diagnosis II vs bipolar
antidepressant therapy type diagnosis II vs I
antidepressant therapy type diagnosis II bipolar
antidepressant therapy type diagnosis II
antidepressant therapy type diagnosis number episodes manic
antidepressant drugs vs therapy type diagnosis structured Patients experienced compared switch manic
antidepressant drugs vs therapy type diagnosis structured Patients experienced compared switch manic hypomanic
antidepressant drugs vs therapy type diagnosis II vs DSM
antidepressant drugs vs therapy type diagnosis II vs IV
antidepressant drugs vs therapy type diagnosis II vs bipolar
antidepressant drugs vs therapy type diagnosis II vs I
antidepressant drugs vs therapy type diagnosis II bipolar
antidepressant drugs vs therapy type diagnosis II
antidepressant drugs vs therapy type diagnosis number episodes manic
serotonin inhibitors drugs vs therapy type diagnosis structured Patients experienced compared switch manic
reuptake inhibitors drugs vs therapy type diagnosis structured Patients experienced compared switch manic
inhibitors drugs vs therapy type diagnosis structured Patients experienced compared switch manic
serotonin inhibitors drugs vs therapy type diagnosis structured Patients experienced compared switch manic hypomanic
reuptake inhibitors drugs vs therapy type diagnosis structured Patients experienced compared switch manic hypomanic
inhibitors drugs vs therapy type diagnosis structured Patients experienced compared switch manic hypomanic
serotonin inhibitors drugs vs therapy type diagnosis II vs DSM
serotonin inhibitors drugs vs therapy type diagnosis II vs IV
serotonin inhibitors drugs vs therapy type diagnosis II vs bipolar
serotonin inhibitors drugs vs therapy type diagnosis II vs I
reuptake inhibitors drugs vs therapy type diagnosis II vs DSM
reuptake inhibitors drugs vs therapy type diagnosis II vs IV
reuptake inhibitors drugs vs therapy type diagnosis II vs bipolar
reuptake inhibitors drugs vs therapy type diagnosis II vs I
inhibitors drugs vs therapy type diagnosis II vs DSM
inhibitors drugs vs therapy type diagnosis II vs IV
inhibitors drugs vs therapy type diagnosis II vs bipolar
inhibitors drugs vs therapy type diagnosis II vs I
serotonin inhibitors drugs vs therapy type diagnosis II bipolar
serotonin inhibitors drugs vs therapy type diagnosis II
reuptake inhibitors drugs vs therapy type diagnosis II bipolar
reuptake inhibitors drugs vs therapy type diagnosis II
inhibitors drugs vs therapy type diagnosis II bipolar
inhibitors drugs vs therapy type diagnosis II
serotonin inhibitors drugs vs therapy type diagnosis number episodes manic
reuptake inhibitors drugs vs therapy type diagnosis number episodes manic
inhibitors drugs vs therapy type diagnosis number episodes manic
SSRIs -RSB- inhibitors drugs vs therapy type diagnosis structured Patients experienced compared switch manic
SSRIs -RSB- inhibitors drugs vs therapy type diagnosis structured Patients experienced compared switch manic hypomanic
SSRIs -RSB- inhibitors drugs vs therapy type diagnosis II vs DSM
SSRIs -RSB- inhibitors drugs vs therapy type diagnosis II vs IV
SSRIs -RSB- inhibitors drugs vs therapy type diagnosis II vs bipolar
SSRIs -RSB- inhibitors drugs vs therapy type diagnosis II vs I
SSRIs -RSB- inhibitors drugs vs therapy type diagnosis II bipolar
SSRIs -RSB- inhibitors drugs vs therapy type diagnosis II
SSRIs -RSB- inhibitors drugs vs therapy type diagnosis number episodes manic
SSRIs -LSB- treated subgroup % / patients % occurred Switches hypomania
SSRIs -LSB- treated subgroup % / patients % occurred Switches hypomania mania
SSRIs -LSB- treated subgroup % / patients % occurred experienced episodes manic
SSRIs -LSB- treated subgroup % / patients % occurred experienced experienced episodes hypomanic
suxamethonium dose spasm masseter
suxamethonium dose spasm
Pethidine associated seizure
pethidine associated seizure
piroxicam dose treated rats found toxicity retardation intrauterine
piroxicam dose treated rats found toxicity retardation growth
piroxicam dose treated rats found toxicity retardation
piroxicam dose treated rats found toxicity increase
piroxicam dose treated rats found toxicity increase variations of
piroxicam dose treated rats found toxicity increase variations external
piroxicam dose treated rats found toxicity increase variations external and
piroxicam dose treated rats found toxicity increase variations external skeletal
piroxicam dose treated rats found toxicity increase variations
BZDs RDs use associated dizziness
BZDs RDs use associated sleep awaking night tiredness
BZDs RDs use associated dizziness inability
BZDs RDs use associated sleep to
BZDs RDs use associated sleep
BZDs RDs use associated sleep awaking symptoms depressive
BZDs RDs use associated sleep awaking symptoms
capecitabine effects diarrhea vomiting
capecitabine effects diarrhea
capecitabine effects diarrhea stomatitis
capecitabine effects diarrhea hand
capecitabine effects diarrhea syndrome foot
capecitabine effects diarrhea syndrome
capecitabine effects diarrhea nausea
alfentanil increases rigidity
alfentanil rigidity
alfentanil used prevented rigidity
fluoxetine medication Increase disability Parkinson
fluoxetine medication Increase disability
fluoxetine exposure disease patients disability motor
fluoxetine exposure disease patients disability
gentamicin therapy sodium combination receiving necrosis acute
gentamicin therapy sodium combination receiving necrosis tubular
gentamicin therapy sodium combination receiving necrosis
sulfate therapy sodium combination receiving necrosis acute
sulfate therapy sodium combination receiving necrosis tubular
sulfate therapy sodium combination receiving necrosis
cephalothin sodium combination receiving necrosis acute
cephalothin sodium combination receiving necrosis tubular
cephalothin sodium combination receiving necrosis
sodium combination receiving necrosis acute
sodium combination receiving necrosis tubular
sodium combination receiving necrosis
propofol pain
propofol pain
propofol pain
amantadine Readministration increased occurred suppression
amantadine Readministration increased occurred suppression motility of
amantadine Readministration increased occurred suppression motility
amantadine mice caused depression behavioral
amantadine mice caused depression
nicotine role disease cardiovascular
nicotine role disease
Nicotine activates contribute disease cardiovascular
Nicotine activates contribute disease
nicotine play role atherosclerosis
morphine produced rigidity muscular
morphine produced rigidity
morphine produced rigidity muscular
morphine produced rigidity
morphine dose given controls Saline showed rigidity
morphine days treated showed differences half animals showed rigidity
morphine dose showed rigidity
morphine days treated showed differences half animals showed akinetic
morphine dose showed akinetic
haloperidol mg used block estimate rigidity
Haloperidol enhanced rigidity
morphine action due assumed rigidity
ibuprofen use associated described child developed Stevens
ibuprofen use associated described syndrome Johnson
ibuprofen use associated described syndrome
dexamethasone atorvastatin effects Anti hypertension
Dexamethasone characterized hypertension
Dex Dexamethasone characterized hypertension
clozapine associated myocarditis
clozapine commencement associated myocarditis
clozapine commencement developed onset myocarditis
clozapine use associated complication Myocarditis
paracetamol doses associated hepatotoxicity
acetaminophen BACKGROUND role alcohol development hepatotoxicity
paracetamol 3 developed failure liver
paracetamol 3 developed failure
paracetamol doses treated patients hepatotoxicity
scopolamine induced impairment memory
scopolamine induced impairment
scopolamine induced attention impairment
scopolamine induced attention of
scopolamine induced attention
scopolamine induced attention and
scopolamine induced attention memory
amoxicillin allergic
amoxicillin allergic reactions
amoxicillin responses had allergic
amoxicillin responses allergic
AX amoxicillin responses had allergic
AX amoxicillin responses allergic
AX allergy
AX tests performed establish diagnosis reaction allergic
AX tests performed establish diagnosis reaction
AX establish diagnosis reaction allergic
AX establish diagnosis reaction
AX test negative performed establish diagnosis reaction allergic
AX test negative performed establish diagnosis reaction
AX group patients allergic
alkylating agents treated Patients have risk development leukemia acute
alkylating agents treated Patients have risk development leukemia nonlymphocytic
alkylating agents treated Patients have risk development leukemia
agents treated Patients have risk development leukemia acute
agents treated Patients have risk development leukemia nonlymphocytic
agents treated Patients have risk development leukemia
alkylating agents associated have risk development leukemia acute
alkylating agents associated have risk development leukemia nonlymphocytic
alkylating agents associated have risk development leukemia
agents associated have risk development leukemia acute
agents associated have risk development leukemia nonlymphocytic
agents associated have risk development leukemia
alkylating agents treated Patients have associated development non
alkylating agents treated Patients have lymphoma Hodgkin
alkylating agents treated Patients have lymphoma Hodgkin '
alkylating agents treated Patients have lymphoma s
alkylating agents treated Patients have lymphoma
agents treated Patients have associated development non
agents treated Patients have lymphoma Hodgkin
agents treated Patients have lymphoma Hodgkin '
agents treated Patients have lymphoma s
agents treated Patients have lymphoma
alkylating agents associated development non
alkylating agents associated have lymphoma Hodgkin
alkylating agents associated have lymphoma Hodgkin '
alkylating agents associated have lymphoma s
alkylating agents associated have lymphoma
agents associated development non
agents associated have lymphoma Hodgkin
agents associated have lymphoma Hodgkin '
agents associated have lymphoma s
agents associated have lymphoma
azathioprine agents associated development non
azathioprine agents associated have lymphoma Hodgkin
azathioprine agents associated have lymphoma Hodgkin '
azathioprine agents associated have lymphoma s
azathioprine agents associated have lymphoma
Ifosfamide encephalopathy
ifosfamide infusion developed myoclonus
ifosfamide findings infusion asterixis presence suggest associated myoclonus
IFX use associated myoclonus
MPTP mediator receptor Cardona neurodegeneration
MPTP METH caused damage CNS
MPTP METH caused damage
METH caused damage CNS
METH caused damage
METH role plays hypothesized selective damage CNS
METH role plays hypothesized selective damage
lidocaine incidence symptoms Transient
lidocaine incidence symptoms neurologic
lidocaine incidence symptoms
prilocaine incidence symptoms Transient
prilocaine incidence symptoms neurologic
prilocaine incidence symptoms
lidocaine anesthesia follow symptoms transient
lidocaine anesthesia follow symptoms neurologic
lidocaine anesthesia follow symptoms
lidocaine anesthesia follow symptoms TNSs
lidocaine prilocaine compares duration risk TNSs
prilocaine compares duration risk TNSs
lidocaine TNSs
lidocaine TNSs receiving patients Nine RESULTS had TNSs
prilocaine had receiving patients 1 Nine patients receiving TNSs
prilocaine had receiving patients 1 Nine RESULTS had TNSs
lidocaine preferable has duration incidence TNSs
Prilocaine preferable has duration incidence TNSs
metronidazole lesion colliculus inferior
metronidazole lesion colliculus
metronidazole lesion
metronidazole lesion encephalopathy
metronidazole lesions inferior
metronidazole lesions colliculus
metronidazole lesions
metronidazole lesions induced encephalopathy
metronidazole induced encephalopathy
metronidazole characteristic considered lesions inferior
metronidazole characteristic considered lesions colliculus
metronidazole characteristic considered lesions
metronidazole characteristic considered lesions CONCLUSIONS encephalopathy
salbutamol effects Tremor
salbutamol effects tremor
salbutamol doses administration assessed tremor
Salbutamol increased severity tremor
carbamazepine presenting reaction erythroderma
carbamazepine Hypersensitivity
carbamazepine presenting reaction leukemoid
carbamazepine presenting reaction
carbamazepine presenting reaction failure renal
carbamazepine presenting reaction failure
carbamazepine presented erythroderma
carbamazepine hypersensitivity
carbamazepine presented erythroderma reaction leukemoid
carbamazepine presented erythroderma reaction
carbamazepine presented erythroderma failure renal
carbamazepine presented erythroderma failure
carbamazepine presented erythroderma hyponatremia
amphetamine ie challenge models hyperactivity
MK ie challenge models hyperactivity
801 ie challenge models hyperactivity
MK antagonist hyperactivity
801 hyperactivity
MK antagonist hyperactivity 801 hyperactivity
801 hyperactivity
amphetamine induced hyperactivity
PAN nephrosis
Puromycin nephrosis
aminonucleoside nephrosis
puromycin aminonucleoside injection induced nephrosis
aminonucleoside injection induced nephrosis
PAN BW injection induced nephrosis
PAN injection days as include phase proteinuria
PAN injection days as include phase proteinuria associated effacement phase proteinuria
Valproate induced encephalopathy
Valproate syndrome encephalopathy
valproate induced encephalopathy
gentamicin L induced loss hearing
gentamicin L induced loss
cimetidine infusion arrest Sinus
cimetidine infusion arrest
cimetidine infusions administration associated development bradyarrhythmias
cimetidine mg continuous hour receiving developed episodes arrest sinus
cimetidine mg continuous hour receiving developed episodes arrest
cimetidine case arrest sinus
cimetidine case arrest
methyl dopa occurring depressions
dopa occurring depressions
gemfibrozil cyclosporin treated patients lovastatin reported Myopathy
lovastatin reported associated myoglobinuria
lovastatin reported associated failure renal
lovastatin reported associated failure
niacin cyclosporin treated patients lovastatin reported Myopathy
cyclosporin treated patients lovastatin reported Myopathy
sodium nitroprusside than greater induced hypotension
nitroprusside than greater induced hypotension
SNP group that lower hypotension
SNP group Hg / Hg mm was SPV hypotension
SNP HEM groups Hg 20 hypotension
scopolamine impaired memory
scopolamine impaired
scopolamine impaired memory improve showed associative s relieved deficit
scopolamine impaired memory improve showed associative s relieved deficit memory of
scopolamine impaired memory improve showed associative s relieved deficit memory associative
scopolamine impaired memory improve showed associative s relieved deficit memory
lidocaine buffered Reduction pain
lidocaine injection associated pain
lidocaine pH adjust solution addition reduce pain
lidocaine receiving quantify severity pain
lidocaine area receiving quantify severity pain
lidocaine score pain
lidocaine score lower score pain
lidocaine adjustment accomplished reduction pain
Carmofur induced disorders organic
Carmofur induced disorders mental
Carmofur induced disorders
carmofur onset female year observed disorder Organic
carmofur onset female year observed disorder mental
carmofur onset female year observed disorder
carmofur onset female year induced leukoencephalopathy
carmofur leukoencephalopathy
raloxifene years associated risk thromboembolism venous
raloxifene years associated risk thromboembolism
Raloxifene associated risk thromboembolism venous
Raloxifene associated risk thromboembolism
cyclosporine levels reduction led relief pain
tacrolimus cyclosporine levels reduction led relief pain
cyclosporine effect Syndrome Pain
tacrolimus cyclosporine effect Syndrome Pain
tranexamic thrombin acid injection fibrinolysis coagulation intravascular
tranexamic thrombin acid injection fibrinolysis coagulation
acid injection fibrinolysis coagulation intravascular
acid injection fibrinolysis coagulation
AMCA acid injection fibrinolysis coagulation intravascular
AMCA acid injection fibrinolysis coagulation
cholesterol diffusion generation modulating hemorrhage ulcer
vitamin D coadministration induced atherosclerosis rats modulating hemorrhage ulcer
D coadministration induced atherosclerosis rats modulating hemorrhage ulcer
2 D coadministration induced atherosclerosis rats modulating hemorrhage ulcer
vitamin D coadministration induced atherosclerosis rats modulating hemorrhage gastric
vitamin D coadministration induced atherosclerosis rats modulating hemorrhage
D coadministration induced atherosclerosis rats modulating hemorrhage gastric
D coadministration induced atherosclerosis rats modulating hemorrhage
2 D coadministration induced atherosclerosis rats modulating hemorrhage gastric
2 D coadministration induced atherosclerosis rats modulating hemorrhage
cholesterol diffusion generation modulating rats atherosclerosis
vitamin D coadministration induced atherosclerosis
D coadministration induced atherosclerosis
2 D coadministration induced atherosclerosis
cholesterol diffusion generation modulating hemorrhage gastric
cholesterol diffusion generation modulating hemorrhage
cholesterol induce atherosclerosis
vitamin D containing oil kg cholesterol induce atherosclerosis
D containing oil kg cholesterol induce atherosclerosis
2 D containing oil kg cholesterol induce atherosclerosis
cholesterol calcium concentration parameters atherosclerotic
cholesterol calcium concentration parameters obtained rats atherosclerotic
Sulfonamides associated anencephaly
Sulfonamides associated anencephaly adjusted AOR syndrome CI atresia AOR 0 % = transverse
Sulfonamides associated anencephaly adjusted AOR syndrome CI atresia AOR 0 % = limb
Sulfonamides associated anencephaly adjusted AOR syndrome CI atresia AOR 0 % = deficiency
Sulfonamides associated anencephaly adjusted AOR syndrome hernia diaphragmatic
Sulfonamides associated anencephaly adjusted AOR syndrome hernia
Sulfonamides associated anencephaly adjusted AOR syndrome CI coarctation
Sulfonamides associated anencephaly adjusted AOR syndrome CI coarctation aorta of
Sulfonamides associated anencephaly adjusted AOR syndrome CI coarctation aorta the
Sulfonamides associated anencephaly adjusted AOR syndrome CI coarctation aorta
Sulfonamides associated anencephaly adjusted AOR syndrome CI atresia choanal
Sulfonamides associated anencephaly adjusted AOR syndrome CI atresia
Sulfonamides associated anencephaly adjusted AOR syndrome hypoplastic
Sulfonamides associated anencephaly adjusted AOR syndrome left
Sulfonamides associated anencephaly adjusted AOR syndrome heart
Sulfonamides associated anencephaly adjusted AOR syndrome
Nitrofurantoins associated anophthalmia microphthalmos
Nitrofurantoins associated anophthalmia microphthalmos lip cleft
Nitrofurantoins associated anophthalmia microphthalmos lip
Nitrofurantoins associated anophthalmia
Nitrofurantoins associated anophthalmia microphthalmos CI syndrome hypoplastic
Nitrofurantoins associated anophthalmia microphthalmos CI syndrome left
Nitrofurantoins associated anophthalmia microphthalmos CI syndrome heart
Nitrofurantoins associated anophthalmia microphthalmos CI syndrome
Nitrofurantoins associated anophthalmia microphthalmos CI syndrome AOR 2 % defects atrial
Nitrofurantoins associated anophthalmia microphthalmos CI syndrome AOR 2 % defects septal
Nitrofurantoins associated anophthalmia microphthalmos CI syndrome AOR 2 % defects
Nitrofurantoins associated anophthalmia microphthalmos lip = cleft
Nitrofurantoins associated anophthalmia microphthalmos lip = palate
nitrofurantoins Sulfonamides associated defects birth
nitrofurantoins Sulfonamides associated defects
Sulfonamides associated defects birth
Sulfonamides associated defects
dexamethasone oxidase Role hypertension
dexamethasone hypertension
dexamethasone hypertension dex HT
dex hypertension
dex HT
Dex SBP increased
Dex SBP
Dex SBP thymus decreased
Dex SBP thymus
Dex SBP thymus 001 P
Dex SBP thymus 001 <
Dex SBP thymus 001 0
Dex SBP thymus 001
Dex SBP and
Dex SBP bodyweights
dex prevent HT
testosterone associated atherosclerosis
testosterone therapy estrogen women atherosclerosis
testosterone therapy affect atherosclerosis
haloperidol induced Catalepsy
thioperamide methylhistamine R cause catalepsy
THP thioperamide methylhistamine R cause catalepsy
THP Administration increase times catalepsy
haloperidol mg THP Administration increase times catalepsy
amphetamine induced hyperactivity
THP exhibited antipsychotic like induced catalepsy
amphetamine reducing like induced hyperactivity
haloperidol potentiating like induced catalepsy
5 initiation
5 initiation induced
5 initiation induced carcinogens by
5 initiation induced carcinogens
azacytidine initiation
azacytidine initiation induced
azacytidine initiation induced carcinogens by
azacytidine initiation induced carcinogens
N pyrene -LSB- carcinogens induced synthesis phase given test plays role initiation
N pyrene -LSB- carcinogens induced synthesis phase given test plays role initiation process of
N pyrene -LSB- carcinogens induced synthesis phase given test plays role initiation process carcinogenic
N pyrene -LSB- carcinogens induced synthesis phase given test plays role initiation process
methyl -LSB- carcinogens induced synthesis phase given test plays role initiation
methyl -LSB- carcinogens induced synthesis phase given test plays role initiation process of
methyl -LSB- carcinogens induced synthesis phase given test plays role initiation process carcinogenic
methyl -LSB- carcinogens induced synthesis phase given test plays role initiation process
N methyl -LSB- carcinogens induced synthesis phase given test plays role initiation
N methyl -LSB- carcinogens induced synthesis phase given test plays role initiation process of
N methyl -LSB- carcinogens induced synthesis phase given test plays role initiation process carcinogenic
N methyl -LSB- carcinogens induced synthesis phase given test plays role initiation process
nitrosourea -LSB- carcinogens induced synthesis phase given test plays role initiation
nitrosourea -LSB- carcinogens induced synthesis phase given test plays role initiation process of
nitrosourea -LSB- carcinogens induced synthesis phase given test plays role initiation process carcinogenic
nitrosourea -LSB- carcinogens induced synthesis phase given test plays role initiation process
benzo -LSB- carcinogens induced synthesis phase given test plays role initiation
benzo -LSB- carcinogens induced synthesis phase given test plays role initiation process of
benzo -LSB- carcinogens induced synthesis phase given test plays role initiation process carcinogenic
benzo -LSB- carcinogens induced synthesis phase given test plays role initiation process
-LSB- carcinogens induced synthesis phase given test plays role initiation
-LSB- carcinogens induced synthesis phase given test plays role initiation process of
-LSB- carcinogens induced synthesis phase given test plays role initiation process carcinogenic
-LSB- carcinogens induced synthesis phase given test plays role initiation process
a -RSB- -LSB- carcinogens induced synthesis phase given test plays role initiation
a -RSB- -LSB- carcinogens induced synthesis phase given test plays role initiation process of
a -RSB- -LSB- carcinogens induced synthesis phase given test plays role initiation process carcinogenic
a -RSB- -LSB- carcinogens induced synthesis phase given test plays role initiation process
-RSB- -LSB- carcinogens induced synthesis phase given test plays role initiation
-RSB- -LSB- carcinogens induced synthesis phase given test plays role initiation process of
-RSB- -LSB- carcinogens induced synthesis phase given test plays role initiation process carcinogenic
-RSB- -LSB- carcinogens induced synthesis phase given test plays role initiation process
pyrene -LSB- carcinogens induced synthesis phase given test plays role initiation
pyrene -LSB- carcinogens induced synthesis phase given test plays role initiation process of
pyrene -LSB- carcinogens induced synthesis phase given test plays role initiation process carcinogenic
pyrene -LSB- carcinogens induced synthesis phase given test plays role initiation process
5 given test plays role initiation
5 given test plays role initiation process of
5 given test plays role initiation process carcinogenic
5 given test plays role initiation process
azacytidine 5 given test plays role initiation
azacytidine 5 given test plays role initiation process of
azacytidine 5 given test plays role initiation process carcinogenic
azacytidine 5 given test plays role initiation process
5 azacytidine 5 given test plays role initiation
5 azacytidine 5 given test plays role initiation process of
5 azacytidine 5 given test plays role initiation process carcinogenic
5 azacytidine 5 given test plays role initiation process
AzC 5 azacytidine 5 given test plays role initiation
AzC 5 azacytidine 5 given test plays role initiation process of
AzC 5 azacytidine 5 given test plays role initiation process carcinogenic
AzC 5 azacytidine 5 given test plays role initiation process
1 nitrosourea -LSB- carcinogens induced synthesis phase given test plays role initiation
1 nitrosourea -LSB- carcinogens induced synthesis phase given test plays role initiation process of
1 nitrosourea -LSB- carcinogens induced synthesis phase given test plays role initiation process carcinogenic
1 nitrosourea -LSB- carcinogens induced synthesis phase given test plays role initiation process
2 1 nitrosourea -LSB- carcinogens induced synthesis phase given test plays role initiation
2 1 nitrosourea -LSB- carcinogens induced synthesis phase given test plays role initiation process of
2 1 nitrosourea -LSB- carcinogens induced synthesis phase given test plays role initiation process carcinogenic
2 1 nitrosourea -LSB- carcinogens induced synthesis phase given test plays role initiation process
dimethylhydrazine -LSB- carcinogens induced synthesis phase given test plays role initiation
dimethylhydrazine -LSB- carcinogens induced synthesis phase given test plays role initiation process of
dimethylhydrazine -LSB- carcinogens induced synthesis phase given test plays role initiation process carcinogenic
dimethylhydrazine -LSB- carcinogens induced synthesis phase given test plays role initiation process
1 dimethylhydrazine -LSB- carcinogens induced synthesis phase given test plays role initiation
1 dimethylhydrazine -LSB- carcinogens induced synthesis phase given test plays role initiation process of
1 dimethylhydrazine -LSB- carcinogens induced synthesis phase given test plays role initiation process carcinogenic
1 dimethylhydrazine -LSB- carcinogens induced synthesis phase given test plays role initiation process
2 1 dimethylhydrazine -LSB- carcinogens induced synthesis phase given test plays role initiation
2 1 dimethylhydrazine -LSB- carcinogens induced synthesis phase given test plays role initiation process of
2 1 dimethylhydrazine -LSB- carcinogens induced synthesis phase given test plays role initiation process carcinogenic
2 1 dimethylhydrazine -LSB- carcinogens induced synthesis phase given test plays role initiation process
DMH 1 dimethylhydrazine -LSB- carcinogens induced synthesis phase given test plays role initiation
DMH 1 dimethylhydrazine -LSB- carcinogens induced synthesis phase given test plays role initiation process of
DMH 1 dimethylhydrazine -LSB- carcinogens induced synthesis phase given test plays role initiation process carcinogenic
DMH 1 dimethylhydrazine -LSB- carcinogens induced synthesis phase given test plays role initiation process
Nicotine induced correlates nystagmus
nicotine pathomechanism nystagmus
nicotine pathomechanism nystagmus NIN
hexafluorodiethyl ether induced Seizures
ether induced Seizures
hexafluorodiethyl ether induced Seizures found seizures
ether induced Seizures found seizures
HFDE Seizures
HFDE Seizures found seizures
HFDE protective induced seizures
amphetamine antagonism localization induced hyperactivity
methamphetamine abusing patients present hygiene caries
methamphetamine use reported experienced episodes carious
methamphetamine use reported experienced episodes
ritonavir treatment increases formation atherosclerotic
ritonavir treatment increases formation lesion
pilocarpine model status
pilocarpine model epilepticus
pilocarpine model evaluated effect PDTC epilepticus status
pilocarpine model evaluated effect PDTC epilepticus
isoproterenol attenuation dose induced tachycardia
isoproterenol tea Effect induced infarction myocardial
isoproterenol tea Effect induced infarction
isoproterenol ATPases infarction myocardial
isoproterenol ATPases infarction
ISO isoproterenol ATPases infarction myocardial
ISO isoproterenol ATPases infarction
ISO induced infarction myocardial
ISO induced infarction
dacarbazine therapy disease Veno
dacarbazine therapy disease occlusive
dacarbazine therapy disease liver
dacarbazine therapy disease
DTIC therapy disease Veno
DTIC therapy disease occlusive
DTIC therapy disease liver
DTIC therapy disease
dacarbazine therapy reported disease case veno
dacarbazine therapy reported disease occlusive
dacarbazine therapy reported disease
dacarbazine therapy reported disease liver of
dacarbazine therapy reported disease liver the
dacarbazine therapy reported disease liver
DTIC therapy reported disease case veno
DTIC therapy reported disease occlusive
DTIC therapy reported disease
DTIC therapy reported disease liver of
DTIC therapy reported disease liver the
DTIC therapy reported disease liver
phenacetin consumption associated cancer necrosis renal
phenacetin consumption associated cancer necrosis papillary
phenacetin consumption associated cancer necrosis
phenacetin consumption fold 20 increased risk necrosis renal
phenacetin consumption fold 20 increased risk necrosis papillary
phenacetin consumption fold 20 increased risk necrosis
isosorbide dinitrate administration infarction Myocardial
isosorbide dinitrate administration infarction
dinitrate administration infarction Myocardial
dinitrate administration infarction
isosorbide dinitrate administration wall infarction myocardial
isosorbide dinitrate administration wall infarction
dinitrate administration wall infarction myocardial
dinitrate administration wall infarction
tacrolimus Cyclosporine microangiopathy thrombotic
tacrolimus Cyclosporine microangiopathy
Cyclosporine microangiopathy thrombotic
Cyclosporine microangiopathy
cyclosporine use associated microangiopathy thrombotic
cyclosporine use associated microangiopathy
cyclosporine use associated microangiopathy TMA
tacrolimus switching reported option TMA
cyclosporine setting option TMA
tacrolimus application recognized TMA
tacrolimus application recognized TMA
tacrolimus cyclosporine exposed patients TMA
cyclosporine exposed patients TMA
cyclosporine developed recipient case TMA
cyclosporine withdrawal responded TMA
tacrolimus Introduction resulted recurrence TMA
tacrolimus switched Patients monitored signs TMA
cyclosporine switched Patients monitored signs TMA
simvastatin ezetimibe published events hepatotoxic
ezetimibe ezetimibe published events hepatotoxic
simvastatin 70 developed failure fulminant
simvastatin 70 developed failure hepatic
simvastatin 70 developed failure
10 mg simvastatin 70 developed failure fulminant
10 mg simvastatin 70 developed failure hepatic
10 mg simvastatin 70 developed failure
mg simvastatin 70 developed failure fulminant
mg simvastatin 70 developed failure hepatic
mg simvastatin 70 developed failure
ezetimibe mg mg simvastatin 70 developed failure fulminant
ezetimibe mg mg simvastatin 70 developed failure hepatic
ezetimibe mg mg simvastatin 70 developed failure
40 mg mg simvastatin 70 developed failure fulminant
40 mg mg simvastatin 70 developed failure hepatic
40 mg mg simvastatin 70 developed failure
mg mg simvastatin 70 developed failure fulminant
mg mg simvastatin 70 developed failure hepatic
mg mg simvastatin 70 developed failure
Simvastatinezetimibe discontinued excluded causes hepatotoxicity
simvastatinezetimibe induced hepatotoxicity
simvastatin hepatotoxicity
ezetimibe aware hepatotoxicity
Serotonergic antidepressants incontinence urinary
Serotonergic antidepressants incontinence
antidepressants incontinence urinary
antidepressants incontinence
venlafaxine taking experienced incontinence
sertraline paroxetine inhibitors incontinence
venlafaxine developed third patients developed inhibitors incontinence
paroxetine inhibitors incontinence
lithium carbonate blockers contributed incontinence
carbonate blockers contributed incontinence
serotonergic antidepressants incontinence
antidepressants incontinence
cyclophosphamide high regimen failure congestive
cyclophosphamide high regimen failure heart
cyclophosphamide high regimen failure
cyclophosphamide high regimen failure CHF
cyclophosphamide CHF
cyclophosphamide monitoring EKG predict development CHF
metoprolol administration Angioedema
lisinopril therapy angioedema
metoprolol given resulting angioedema
Octreotide induced hypertension hypoxemia pulmonary
Octreotide induced hypertension
octreotide developed hypertension Pulmonary
octreotide developed hypertension
labetalol comparison hypotension
nitroprusside labetalol comparison hypotension
labetalol hypotension hypotension
labetalol hypotension
nitroprusside hypotension
nitroprusside hypotension hypotension
nitroprusside discontinuation observed associated increase
nitroprusside discontinuation observed associated increase rate in
nitroprusside discontinuation observed associated increase rate heart
nitroprusside discontinuation observed associated increase rate
nitroprusside discontinuation observed associated increase rate and
nitroprusside discontinuation observed associated increase rate output cardiac
nitroprusside discontinuation observed associated increase rate output
cyproterone acetate prescribed women thromboembolism venous
cyproterone acetate prescribed women thromboembolism
acetate prescribed women thromboembolism venous
acetate prescribed women thromboembolism
ethinyl estradiol prescribed women thromboembolism venous
ethinyl estradiol prescribed women thromboembolism
estradiol prescribed women thromboembolism venous
estradiol prescribed women thromboembolism
CPA EE associated thromboembolism venous
CPA EE associated thromboembolism
CPA EE associated thromboembolism VTE
EE associated thromboembolism venous
EE associated thromboembolism
EE associated thromboembolism VTE
CPA EE associated VTE
EE associated VTE
CPA EE use associated VTE
EE use associated VTE
5 patients supervision discontinued observed pain chest
5 patients supervision discontinued observed pain
FU treatment supervision discontinued observed pain chest
FU treatment supervision discontinued observed pain
fentanyl infusion result urine retention
fentanyl infusion result urine of
fentanyl infusion result urine
fentanyl administration effects include rigidity hypotension
fentanyl administration effects include rigidity depression respiratory
fentanyl administration effects include rigidity depression
fentanyl administration effects include rigidity bradycardia
fentanyl infusion result mimicking leading retention urinary
fentanyl infusion result mimicking leading retention bladder
fentanyl infusion result mimicking leading retention
valproate added induced Encephalopathy
levetiracetam induced Encephalopathy
levetiracetam manifestation report encephalopathy
LEV levetiracetam manifestation report encephalopathy
ifosfamide toxicity renal
ifosfamide toxicity
MZ use caused hypoxia presented event hypoxia
MZ use caused hypoxia presented hypoxia
MZ use caused hypoxia
methyldopa induced Patterns injury hepatic
methyldopa induced Patterns injury
methyldopa episode recommenced hepatitis
methyldopa dysfunction relationship proved recurrence hepatitis
streptomycin sensitive indicating occurred occurred movements Abnormal
streptomycin sensitive indicating occurred occurred movements
streptomycin site responsible dyskinesias
streptomycin sensitive indicating occurred occurred movements deafness
noradrenaline infusion caused hypertension
noradrenaline infusion hypertension
noradrenaline circulating levels produced hypertension
caffeine administration onset convulsions
caffeine administration interval increased acetaminophen pretreatment pretreatment acetaminophen reduced incidence seizures
caffeine presence produced incidence reduced acetaminophen pretreatment pretreatment acetaminophen increased interval administration onset convulsions
caffeine presence produced incidence seizures
caffeine 5 seizures
pentylenetetrezol dose alter modify seizures
caffeine absence modify seizures
cimetidine was only dementia
cimetidine levels had disease liver was only dementia
cimetidine levels induce dementia
terbutaline treatment associated complications Cardiovascular
terbutaline treatment associated complications
terbutaline treated patients eight occurred complications cardiovascular
terbutaline treated patients eight occurred complications
Ticlopidine induced anemia aplastic
Ticlopidine induced anemia
ticlopidine induced anemia aplastic
ticlopidine induced anemia
ticlopidine initiation weeks recommended occurred Agranulocytosis
ticlopidine induced anemia aplastic
ticlopidine induced anemia
morphine administration induced learning impairment
morphine administration induced learning of
morphine administration induced learning
morphine administration learning
morphine administration learning impairment
isoniazid therapy due convulsions
isoniazid mg infant day 17 kg admitted days fits clonic
isoniazid mg infant day 17 kg admitted days fits
isoniazid medication suggesting ceased fits
didanosine normal returned mild developed characteristic glucose
didanosine normal returned mild developed characteristic tolerance
didanosine normal returned mild developed characteristic curves
ACE inhibitors due Angioedema
inhibitors due Angioedema
angiotensin incidence angioedema
converting 1 incidence angioedema
enzyme treatment converting 1 incidence angioedema
ACE enzyme treatment converting 1 incidence angioedema
inhibitor treatment converting 1 incidence angioedema
chlorhexidine factor digluconate associated cystitis
digluconate associated cystitis
kanamycin percentage iodine associated cystitis
povidone colistin percentage iodine associated cystitis
iodine associated cystitis
colistin percentage iodine associated cystitis
doxorubicin damage myocardial
doxorubicin damage
doxorubicin damage markers I Evaluation rats cardiomyopathy
doxorubicin model damage myocardial
doxorubicin model damage
doxorubicin model damage diagnosis investigated induced cardiomyopathy
DOX doxorubicin model damage myocardial
DOX doxorubicin model damage
DOX doxorubicin model damage diagnosis investigated induced cardiomyopathy
DOX injury markers showed detect damage myocardial
DOX injury markers showed detect damage
docetaxel cancer combination thromboembolism frequency venous
docetaxel cancer combination thromboembolism
thalidomide docetaxel cancer combination thromboembolism frequency venous
thalidomide docetaxel cancer combination thromboembolism
docetaxel treated cancer frequency thromboembolism venous
docetaxel treated cancer frequency thromboembolism
docetaxel treated cancer frequency thromboembolism VTE
thalidomide treated cancer frequency thromboembolism venous
thalidomide treated cancer frequency thromboembolism
thalidomide treated cancer frequency thromboembolism VTE
docetaxel developed VTE
docetaxel developed developed VTE
docetaxel thalidomide received patients 9 developed developed VTE
docetaxel thalidomide received patients 9 developed VTE
thalidomide received patients 9 developed developed VTE
thalidomide received patients 9 developed VTE
docetaxel addition CONCLUSION increases frequency VTE
thalidomide addition CONCLUSION increases frequency VTE
cocaine abusers Eleven had evidence injury defined infarction block bundle
cocaine abusers Eleven had evidence injury defined infarction block branch
cocaine abusers Eleven had evidence injury defined infarction block
cocaine abusers Eleven had evidence injury defined infarction myocardial
cocaine abusers Eleven had evidence injury defined infarction
telithromycin attack hepatitis
telithromycin usage occurred hepatitis
telithromycin cause hepatitis
telithromycin cause suggested drug induced hepatitis toxic
telithromycin cause suggested drug induced hepatitis
telithromycin prescribed physician communicated avoided Recurrence attack hepatitis
telithromycin administration associated hepatitis
paracetamol aspirin developed necrosis Renal
paracetamol aspirin developed necrosis papillary
paracetamol aspirin developed necrosis
paracetamol aspirin developed necrosis RPN
aspirin developed necrosis Renal
aspirin developed necrosis papillary
aspirin developed necrosis
aspirin developed necrosis RPN
dexamethasone programs injury hypertension
dexamethasone programs injury hypertension renal
dexamethasone programs injury
dexamethasone programmed increase
dexamethasone programmed pressure in
dexamethasone programmed pressure blood
dexamethasone programmed pressure
dexamethasone programmed pressure injury renal
dexamethasone programmed pressure injury
dexamethasone gestation administered rats Offspring had reduction
dexamethasone gestation administered rats Offspring had reduction number in
dexamethasone gestation administered rats Offspring had reduction number glomerular
dexamethasone gestation administered rats Offspring had reduction number
dexamethasone received rats had pressures elevated
dexamethasone received rats had pressures blood
dexamethasone received rats had pressures
dexamethasone received rats had have reduction
dexamethasone received rats had have reduction number in
dexamethasone received rats had have reduction number glomerular
dexamethasone received rats had have reduction number
dexamethasone shows results reduction number hypertension
dexamethasone shows results reduction
dexamethasone shows results reduction number in
dexamethasone shows results reduction number glomerular
dexamethasone shows results reduction number
methamphetamine hyperthermia
Triamterene nephrolithiasis
triamterene nephrolithiasis
triamterene nephrolithiasis
carbamazepine phenobarbitone rats dysfunction cognitive
carbamazepine phenobarbitone rats dysfunction
phenobarbitone rats dysfunction cognitive
phenobarbitone rats dysfunction
carbamazepine drugs known cause impairment cognitive
carbamazepine drugs known cause impairment
phenobarbitone drugs known cause impairment cognitive
phenobarbitone drugs known cause impairment
carbamazepine phenobarbitone impairment cognitive
carbamazepine phenobarbitone impairment
phenobarbitone impairment cognitive
phenobarbitone impairment
carbamazepine phenobarbitone administration caused impairment
carbamazepine phenobarbitone administration caused impairment learning of
carbamazepine phenobarbitone administration caused impairment learning
carbamazepine phenobarbitone administration caused impairment learning and
carbamazepine phenobarbitone administration caused impairment learning memory
phenobarbitone administration caused impairment
phenobarbitone administration caused impairment learning of
phenobarbitone administration caused impairment learning
phenobarbitone administration caused impairment learning and
phenobarbitone administration caused impairment learning memory
carbamazepine phenobarbitone treated rats mitigating deterioration
carbamazepine phenobarbitone treated rats mitigating deterioration functions of
carbamazepine phenobarbitone treated rats mitigating deterioration functions cognitive
carbamazepine phenobarbitone treated rats mitigating deterioration functions
phenobarbitone treated rats mitigating deterioration
phenobarbitone treated rats mitigating deterioration functions of
phenobarbitone treated rats mitigating deterioration functions cognitive
phenobarbitone treated rats mitigating deterioration functions
carbamazepine phenobarbitone preventing impairment cognitive
carbamazepine phenobarbitone preventing impairment
phenobarbitone preventing impairment cognitive
phenobarbitone preventing impairment
SRL seems nephrotoxic
SRL seems act displaying effects nephrotoxic
SRL combined number described indications effect nephrotoxic
SRL CsA effect nephrotoxic
SRL 506 tolerated demonstrated effect nephrotoxic
FK 506 tolerated demonstrated effect nephrotoxic
506 tolerated demonstrated effect nephrotoxic
CsA effect nephrotoxic
ritodrine therapy section tachyarrhythmias Ventricular
ritodrine therapy section tachyarrhythmias
scopolamine depletion induced deficits memory
scopolamine depletion induced deficits
pilocarpine SE
lithium subjected rats estradiol effects pilocarpine SE
Clomipramine induced disturbance sleep
Clomipramine induced disturbance
clomipramine administration induced disturbance sleep
clomipramine administration induced disturbance
ciprofloxacin associated thrombocytopenia anaemia haemolytic
ciprofloxacin associated thrombocytopenia anaemia
ciprofloxacin associated thrombocytopenia
ciprofloxacin administration 30 man reported pain abdominal
ciprofloxacin administration 30 man reported pain
ciprofloxacin administration 30 man reported pain jaundice
ciprofloxacin precipitate life thrombocytopenia anaemia haemolytic
ciprofloxacin precipitate life thrombocytopenia anaemia
ciprofloxacin precipitate life thrombocytopenia
norepinephrine caused bradycardia
norepinephrine had enhanced bradycardia
norepinephrine caused bradycardia
norepinephrine decreased bradycardia
prostaglandin E Epidural trimethaphan hypotension
E Epidural trimethaphan hypotension
1 E Epidural trimethaphan hypotension
trimethaphan hypotension
prostaglandin E trimethaphan induced hypotension
E trimethaphan induced hypotension
1 E trimethaphan induced hypotension
PGE 1 E trimethaphan induced hypotension
1 PGE 1 E trimethaphan induced hypotension
trimethaphan induced hypotension
TMP trimethaphan induced hypotension
PGE starting decreased remained degree hypotension
1 PGE starting decreased remained degree hypotension
PGE due hypotension
1 PGE due hypotension
TMP PGE starting decreased remained degree hypotension
PGE preferable TMP anaesthesia hypotensive
1 PGE preferable TMP anaesthesia hypotensive
TMP anaesthesia hypotensive
TMP decreased preferable TMP anaesthesia hypotensive
tobramycin sulfate sulfate day followed failure renal
tobramycin sulfate sulfate day followed failure
sulfate sulfate day followed failure renal
sulfate sulfate day followed failure
gentamicin sulfate day followed failure renal
gentamicin sulfate day followed failure
sulfate day followed failure renal
sulfate day followed failure
tobramycin 33 Five treated had failure renal
tobramycin 33 Five treated had failure
gentamicin 29 16 patients treated Five treated had failure renal
gentamicin 29 16 patients treated Five treated had failure
tobramycin times failure renal
tobramycin times failure
gentamicin associated failure renal
gentamicin associated failure
PTZ pentylenetrazol decrease threshold seizure
PTZ pentylenetrazol h seizures
PTZ threshold h pentylenetrazol decrease threshold seizure
PTZ threshold h seizures
methyl acid 3 due activity different decreased activity Seizure
6 methyl acid 3 due activity different decreased activity Seizure
7 methyl acid 3 due activity different decreased activity Seizure
dimethoxy 3 due activity different decreased activity Seizure
4 3 due activity different decreased activity Seizure
ethyl 3 due activity different decreased activity Seizure
B 3 due activity different decreased activity Seizure
carboline 3 due activity different decreased activity Seizure
3 3 due activity different decreased activity Seizure
carboxylate 3 due activity different decreased activity Seizure
methyl acid 3 due activity seizure
6 methyl acid 3 due activity seizure
7 methyl acid 3 due activity seizure
dimethoxy 3 due activity seizure
4 3 due activity seizure
ethyl 3 due activity seizure
B 3 due activity seizure
carboline 3 due activity seizure
3 3 due activity seizure
carboxylate 3 due activity seizure
DMCM carboxylate 3 due activity different decreased activity Seizure
DMCM carboxylate 3 due activity seizure
picrotoxin activity Seizure
picrotoxin activity decreased different activity seizure
PTX picrotoxin activity Seizure
PTX picrotoxin activity decreased different activity seizure
strychnine 3 due activity different decreased activity Seizure
strychnine 3 due activity seizure
STR activity different decreased activity Seizure
STR activity seizure
PTZ due activity Seizure
PTZ due activity decreased different activity seizure
3 due activity different decreased activity Seizure
mercaptopropionic acid 3 due activity different decreased activity Seizure
acid 3 due activity different decreased activity Seizure
3 due activity seizure
mercaptopropionic acid 3 due activity seizure
acid 3 due activity seizure
MPA acid 3 due activity different decreased activity Seizure
MPA acid 3 due activity seizure
bicuculline acid 3 due activity different decreased activity Seizure
bicuculline acid 3 due activity seizure
BCC bicuculline acid 3 due activity different decreased activity Seizure
BCC bicuculline acid 3 due activity seizure
PTX occur activity seizure
PTX occur suggest decreased HCH response seizure
PTZ induced activity seizure
PTZ induced activity occur suggest decreased HCH response seizure
cisplatin paclitaxel drugs neurons cultures exposing mimic neuropathy peripheral
cisplatin paclitaxel drugs neurons cultures exposing mimic neuropathy
paclitaxel drugs neurons cultures exposing mimic neuropathy peripheral
paclitaxel drugs neurons cultures exposing mimic neuropathy
prostaglandin E effects hypotension
E effects hypotension
1 E effects hypotension
prostaglandin E hypotension
E hypotension
1 E hypotension
PGE 1 E hypotension
1 PGE 1 E hypotension
PGE induced hypotension
1 PGE induced hypotension
PGE min combination cause impairment
PGE min combination cause impairment function of
PGE min combination cause impairment function hepatic
PGE min combination cause impairment function
1 PGE min combination cause impairment
1 PGE min combination cause impairment function of
1 PGE min combination cause impairment function hepatic
1 PGE min combination cause impairment function
PGE min hypotension
1 PGE min hypotension
Simvastatin induced syndrome compartment
Simvastatin induced syndrome
simvastatin thyroxine presented syndrome compartment
simvastatin thyroxine presented syndrome
Fucoidan treated exhibited evidence blood impaired
Fucoidan treated exhibited evidence blood
Fucoidan treated exhibited evidence blood clotting
Fucoidan treated exhibited evidence blood hemodilution
acitretin dysphonia
acitretin treated complaining dysphonia
acitretin case dysphonia
puromycin aminonucleoside course induced nephropathy
aminonucleoside course induced nephropathy
puromycin aminonucleoside pathogenesis implicated induced antioxidants reducing proteinuria
aminonucleoside pathogenesis implicated induced antioxidants reducing proteinuria
PAN aminonucleoside pathogenesis implicated induced antioxidants reducing proteinuria
puromycin aminonucleoside pathogenesis implicated induced nephropathy
aminonucleoside pathogenesis implicated induced nephropathy
PAN aminonucleoside pathogenesis implicated induced nephropathy
PAN injury proteinuric
PAN injury
PAN injury mediating nephropathy
haloperidol indicated developed moderate signs extrapyramidal
haloperidol indicated developed moderate signs
scopolamine non induced amnesia
S non induced amnesia
- non induced amnesia
ET non induced amnesia
126 non induced amnesia
Selegiline hypotension postural
Selegiline hypotension
selegiline therapy associated hypotension systolic
selegiline therapy associated hypotension orthostatic
selegiline therapy associated hypotension
selegiline withdrawal abolished hypotension systolic
selegiline withdrawal abolished hypotension orthostatic
selegiline withdrawal abolished hypotension
selegiline stopping shed mechanisms causes hypotension orthostatic
selegiline stopping shed mechanisms causes hypotension
selegiline marked hypotension systolic
selegiline marked hypotension orthostatic
selegiline marked hypotension
selegiline withdrawal ameliorated hypotension Orthostatic
selegiline withdrawal ameliorated hypotension
selegiline Stopping reduced
selegiline Stopping reduced blood the
selegiline Stopping reduced blood supine
selegiline Stopping reduced blood systolic
selegiline Stopping reduced blood systolic and
selegiline Stopping reduced blood systolic diastolic
selegiline Stopping reduced blood
selegiline Stopping pressures
selegiline finding confirms associated hypotension orthostatic
selegiline finding confirms associated hypotension
mexiletine group frequent effects tremor problems gastrointestinal
mexiletine group frequent effects tremor problems
mexiletine group frequent effects tremor
terodiline terfenadine g market led effect side TDP
terfenadine g market led effect side TDP
terodiline terfenadine compounds known increase cause investigated TDP
cisapride terfenadine compounds known increase cause investigated TDP
terfenadine compounds known increase cause investigated TDP
terodiline cisapride clinic TDP
cisapride clinic TDP
terfenadine cisapride clinic TDP
cefazedone beagle cefonicid dogs administration caused dose incidence anemia neutropenia
cefonicid dogs administration caused dose incidence anemia neutropenia
cefazedone beagle cefonicid dogs administration caused dose incidence anemia thrombocytopenia
cefonicid dogs administration caused dose incidence anemia
cefazedone beagle cefonicid dogs administration caused dose incidence anemia
cefonicid dogs administration caused dose incidence anemia thrombocytopenia
cefonicid mg receiving dogs % occurred compromising anemia
cefazedone kg mg receiving dogs % occurred compromising anemia
isoproterenol Crataegus tincture effect infarction myocardial
isoproterenol Crataegus tincture effect infarction
ethinyl treatment used models cholestasis intrahepatic
ethinyl treatment used models cholestasis
estradiol treatment used models cholestasis intrahepatic
estradiol treatment used models cholestasis
EE treatment used models cholestasis intrahepatic
EE treatment used models cholestasis
isoniazid unmasked disorder behavioral
isoniazid unmasked disorder
isoniazid administration difficulties hyperkinesis had deterioration behavioral
isoniazid administration difficulties hyperkinesis had deterioration
isoniazid administration difficulties hyperkinesis
clioquinol dose ingestion related encephalopathy
levodopa stimulation dyskinesias
octreotide associated stones gall
octreotide associated stones bladder
octreotide associated stones
Octreotide induces stones gall
Octreotide induces stones bladder
Octreotide induces stones
octreotide treated stones gall
octreotide treated stones
octreotide stones gall
octreotide stones
octreotide stones small have common disease gall
octreotide stones small have common disease stone
octreotide stones small have common disease
octreotide stones small have duct stones gall
octreotide stones small have duct stones
metoclopramide caused case dyskinesia tardive
metoclopramide caused case dyskinesia
metoclopramide took patient appeared movements Abnormal
metoclopramide took patient appeared movements involuntary
metoclopramide took patient appeared movements
metoclopramide administration discontinued improved movements abnormal
metoclopramide administration discontinued improved movements
Cocaine induced disorder mood
Cocaine induced disorder
cocaine induced disorder mood
cocaine induced disorder
cocaine induced disorder mood
cocaine induced disorder
cocaine induced disorder disorders mood
cocaine induced disorder disorders
cocaine compared disorder mood
cocaine compared disorder
cocaine outpatients cocaine induced disorder mood
cocaine outpatients cocaine induced disorder
cocaine outpatients cocaine induced disorder disorders mood
cocaine outpatients cocaine induced disorder disorders
cocaine outpatients cocaine compared disorder mood
cocaine outpatients cocaine compared disorder
caffeine concentration containing consuming developed fibrillation ventricular
caffeine concentration containing consuming developed fibrillation
nicotine necessary induced seizures
nicotine Binding series behaviors go seizures
nicotine examined homozygous seizures
nicotine effects sensitive / induced seizures
nicotine measured doses sensitive sensitive / induced seizures
nicotine induced seizures
nicotine mediators induced seizures
GVG effects dopamine explored success risk defects visual
GVG effects dopamine explored success risk defects field
GVG effects dopamine explored success risk defects
GVG effects dopamine explored success risk defects VFD
Ro blocker induced alterations cardiovascular
Ro blocker induced alterations
40 Ro blocker induced alterations cardiovascular
40 Ro blocker induced alterations
5967 Ro blocker induced alterations cardiovascular
5967 Ro blocker induced alterations
verapamil significant observed incidence malformations cardiovascular
verapamil significant observed incidence malformations
nifedipine verapamil significant observed incidence malformations cardiovascular
nifedipine verapamil significant observed incidence malformations
Procainamide induced tachycardia ventricular
Procainamide induced tachycardia
procainamide cases polymorphous presented tachycardia ventricular
procainamide cases polymorphous presented tachycardia
procainamide mg administration appeared tachycardia ventricular
procainamide mg administration appeared tachycardia
procainamide mg administration appeared treatment tachycardia ventricular
procainamide mg administration appeared treatment tachycardia
procainamide therapy continuation inserted polymorphous reoccur tachycardia ventricular
procainamide therapy continuation inserted polymorphous reoccur tachycardia
procainamide produce Q syndrome tachycardia ventricular
procainamide produce Q syndrome tachycardia
bupivacaine triamcinolone injection caused syndrome cauda
bupivacaine triamcinolone injection caused syndrome equina
bupivacaine triamcinolone injection caused syndrome
Apomorphine selected effects ability induce hypothermia
apomorphine induced hyperactivity
apomorphine drug hypothermia
haloperidol efficacy studies model catalepsy
succinylcholine apnea
succinylcholine action duration patients eleven had indicating reason period apnea
risperidone reduction developed RS
risperidone profile related mechanism development RS
methadone associated movements Choreoathetoid
methadone associated movements
methadone report movements euphoria choreoathetoid
methadone report movements
cocaine heroine abusing methadone report movements euphoria choreoathetoid
cocaine heroine abusing methadone report movements
benzoylecgonine induced Seizures
cocaine benzoylecgonine induced Seizures
cocaine life short occur some seizures
benzoylecgonine cocaine metabolite potential evaluated cause seizures
BE benzoylecgonine cocaine metabolite potential evaluated cause seizures
cocaine metabolite potential evaluated cause seizures
BE occurred seizures
cocaine amounts induced those latencies had occurred seizures
BE induced those prolonged characterized cocaine seizures
cocaine seizures
BE rats have had seizures
BE injected seizures
cocaine had seizures
cocaine had have rats BE injected seizures
BE cocaine seizures
BE cocaine seizures differ finding suggests mechanism seizures
BE metabolite importance emphasizes suggests finding differ seizures
BE metabolite importance emphasizes suggests mechanism seizures
cocaine seizures
cocaine seizures differ finding suggests mechanism seizures
cocaine mechanism suggests finding differ seizures
cocaine mechanism seizures
cocaine metabolite importance emphasizes suggests finding differ seizures
cocaine metabolite importance emphasizes suggests mechanism seizures
mazindol effects included appetite symptoms gastrointestinal
mazindol effects included appetite symptoms
mazindol dosage reduced included appetite symptoms gastrointestinal
mazindol dosage reduced included appetite symptoms
mazindol effects included appetite decreased
mazindol effects included appetite
mazindol dosage reduced included appetite decreased
mazindol dosage reduced included appetite
mazindol effects included appetite mouth dry
mazindol effects included appetite mouth
mazindol dosage reduced included appetite mouth dry
mazindol dosage reduced included appetite mouth
methamphetamine induced NRA hyperactivity
MAP methamphetamine induced NRA hyperactivity
NRA 0160 induced catalepsy
0160 induced catalepsy
clozapine 0160 induced catalepsy
lithium Attenuation diabetes
lithium Attenuation diabetes insipidus
lithium Attenuation syndrome like
lithium Attenuation syndrome
lithium attenuation diabetes
lithium attenuation insipidus
lithium attenuation syndrome like
lithium attenuation syndrome
lithium concentration ratio reduction accompanied attenuation diabetes
lithium concentration ratio reduction accompanied attenuation insipidus
lithium concentration ratio reduction accompanied attenuation syndrome like
lithium concentration ratio reduction accompanied attenuation syndrome
cocaine user man presented occasions history priapism
cocaine use presented occasions history priapism
pilocarpine neurotransmitters urea effects seizure
pilocarpine rats seizure
pilocarpine protect finding seizure
pilocarpine reduce finding induced seizure
pilocarpine observed partly account induced finding induced seizure
desipramine toxicity tachycardia ventricular
desipramine toxicity tachycardia
desipramine toxicity induced tachycardia ventricular
desipramine toxicity induced tachycardia
quinine containing products produce complications confusion
quinine containing products produce complications confusion seizures
quinine containing products produce complications confusion coma
Clotiazepam induced hepatitis
clotiazepam administration onset developed hepatitis
clotiazepam related administration interfere induce relapse hepatitis
clotiazepam induce hepatitis
clotiazepam induce shows suggests is hepatotoxicity
clotiazepam benzodiazepines hepatotoxicity is suggests shows induce hepatitis
clotiazepam benzodiazepines hepatotoxicity
statin therapy associated myopathy
Statins cause myopathy
statins induce myopathy
statins initiate immune myopathy
statins involve uncertain mechanism myopathy
Warfarin induced palsy femoral
Warfarin induced palsy nerve
Warfarin induced palsy
warfarin therapy man 28 case sustained tear muscle
warfarin therapy man 28 case sustained tear
warfarin form represents palsy femoral
warfarin form represents palsy nerve
warfarin form represents palsy
haloperidol treatments change uptake dyskinesia orofacial
haloperidol treatments change uptake dyskinesia
reserpine treatments change uptake dyskinesia orofacial
reserpine treatments change uptake dyskinesia
haloperidol Reserpine dyskinesia orofacial
haloperidol Reserpine dyskinesia
haloperidol Reserpine dyskinesia models dyskinesia tardive
haloperidol Reserpine dyskinesia models dyskinesia
haloperidol Reserpine dyskinesia models TD
Reserpine dyskinesia orofacial
Reserpine dyskinesia
Reserpine dyskinesia models dyskinesia tardive
Reserpine dyskinesia models dyskinesia
Reserpine dyskinesia models TD
haloperidol administration reserpine induced dyskinesia orofacial
haloperidol administration reserpine induced dyskinesia
reserpine induced dyskinesia orofacial
reserpine induced dyskinesia
warfarin induced haemorrhage Cerebral
warfarin induced haemorrhage
warfarin frequency evaluate induced due haemorrhages cerebral
warfarin frequency evaluate induced due haemorrhages
warfarin due haemorrhages cerebral
warfarin due haemorrhages
warfarin warfarin due haemorrhages cerebral
warfarin warfarin due haemorrhages
warfarin evaluate studied caused haemorrhage cerebral
warfarin evaluate studied caused haemorrhage
warfarin warfarin evaluate studied caused haemorrhage cerebral
warfarin warfarin evaluate studied caused haemorrhage
warfarin related treatment assessed patients haemorrhage cerebral
warfarin related treatment assessed patients haemorrhage
Warfarin CONCLUSIONS problem haemorrhages cerebral
Warfarin CONCLUSIONS problem haemorrhages
warfarin proportion prevented haemorrhages cerebral
warfarin proportion prevented haemorrhages
warfarin interact known taken prevented haemorrhages cerebral
warfarin interact known taken prevented haemorrhages
cyclosporine drug cause microangiopathy thrombotic
cyclosporine drug cause microangiopathy
Amiodarone induced block sinoatrial
Amiodarone induced block
amiodarone administration observed block sinoatrial
amiodarone administration observed block
amiodarone dosage Reduction resulted disappearance block sinoatrial
amiodarone dosage Reduction resulted disappearance block
cocaine microinjected HT hyperactivity locomotor
cocaine microinjected HT hyperactivity
cocaine induced locomotor
cocaine induced hyperactivity
cocaine prior induced hyperactivity locomotor
cocaine prior induced hyperactivity
CP antagonist effects consisting modification core shell microinjected indicate modified hyperlocomotion
93129 CP antagonist effects consisting modification core shell microinjected indicate modified hyperlocomotion
cocaine hyperlocomotion
ampicillin caused multiforme myocarditis hypersensitivity
ampicillin caused multiforme myocarditis
ampicillin caused multiforme Erythema
ampicillin caused multiforme
ampicillin caused multiforme myocarditis hypersensitivity
ampicillin caused multiforme myocarditis
ampicillin caused multiforme erythema
ampicillin caused multiforme
tamoxifen induced erythrocytes Hemolysis
Tamoxifen induces changes shape erythrocytes anemia hemolytic
Tamoxifen induces changes shape erythrocytes anemia
TAM Tamoxifen induces changes shape erythrocytes anemia hemolytic
TAM Tamoxifen induces changes shape erythrocytes anemia
TAM effects evaluates erythrocytes induced anemia hemolytic
TAM effects evaluates erythrocytes induced anemia
TAM mechanisms identify attempting erythrocytes induced anemia hemolytic
TAM mechanisms identify attempting erythrocytes induced anemia
TAM induces hemolysis
TAM induces variable extension hemolysis
TAM induces hemolysis
TAM effect hemolytic
TAM effect prevented indicating related TAM hemolysis
TAM related indicating prevented effect hemolytic
TAM hemolysis
TAM determined consumption hemolysis
TAM caused Hemolysis
TAM caused Hemolysis preceded excluding colloid mechanism hemolysis
TAM incorporation related protection hemolysis
TAM results hemolysis
TAM promoted stability decreased resulting anemia hemolytic
TAM promoted stability decreased resulting anemia
pilocarpine rats seizures
alcohol ingestion hour developed flushing face tachycardia
alcohol ingestion hour developed flushing face dyspnea
alcohol ingestion hour developed flushing
alcohol ingestion hour developed flushing face of
alcohol ingestion hour developed flushing face the
alcohol ingestion hour developed flushing face
troleandomycin cholestasis
troleandomycin induced hepatitis
troleandomycin case report followed cholestasis
troleandomycin case report followed hepatitis
troleandomycin administration occurred Jaundice
troleandomycin administration occurred associated hypereosinophilia
troleandomycin follow cholestasis
troleandomycin induced hepatitis
clozapine treatment Delirium
clozapine treatment delirium
clozapine treated reviewed incidence delirium
clozapine % found Delirium
azithromycin induced nephritis interstitial
azithromycin induced nephritis
azithromycin recurrent reported nephritis interstitial
azithromycin recurrent reported nephritis
L model analysis DOPA dyskinesia
DOPA dyskinesia
L complications dyskinesia
DOPA L complications dyskinesia
L complications dyskinesia LID
DOPA L complications dyskinesia LID
L treatment arise complications dyskinesia
DOPA arise complications dyskinesia
L treatment arise complications dyskinesia LID
DOPA arise complications dyskinesia LID
L treated allocated groups based presence LID
DOPA allocated groups based presence LID
clozapine threshold agranulocytosis
clozapine agranulocytosis
pentobarbital caused Learning rats amnesia
pentobarbital produced amnesia
haloperidol catalepsy
clonidine treated subjects bradycardia
clonidine treated those treated subjects bradycardia
clonidine monitor bradycardia
methotrexate taking co associated found common Impotence
Acetaminophen induced hypotension
acetaminophen demonstrated produce symptoms anaphylaxis hypotension
acetaminophen administration developed episodes hypotension
acetaminophen consider patients hypotension
Oral contraceptives risk infarction myocardial
Oral contraceptives risk infarction
contraceptives risk infarction myocardial
contraceptives risk infarction
oral contraceptives use risk infarction myocardial
oral contraceptives use risk infarction
contraceptives use risk infarction myocardial
contraceptives use risk infarction
oral contraceptives levonorgestrel dose presence identified years had infarction myocardial
oral contraceptives levonorgestrel dose presence identified years had infarction
contraceptives levonorgestrel dose presence identified years had infarction myocardial
contraceptives levonorgestrel dose presence identified years had infarction
oral contraceptives levonorgestrel 925 women had infarction myocardial
oral contraceptives levonorgestrel 925 women had infarction
contraceptives levonorgestrel 925 women had infarction myocardial
contraceptives levonorgestrel 925 women had infarction
oral contraceptive type used women infarction myocardial
oral contraceptive type used women infarction
contraceptive type used women infarction myocardial
contraceptive type used women infarction
oral contraceptives generation women increased risk infarction myocardial
oral contraceptives generation women increased risk infarction
contraceptives generation women increased risk infarction myocardial
contraceptives generation women increased risk infarction
oral contraceptives used women similar risk infarction myocardial
oral contraceptives used women similar risk infarction
contraceptives used women similar risk infarction myocardial
contraceptives used women similar risk infarction
WR postinjection noted hemoglobinuria
242511 WR postinjection noted hemoglobinuria
atracurium use Persistent paralysis
vecuronium bromide NMBAs aminosteroid involved Reports paralysis
bromide NMBAs aminosteroid involved Reports paralysis
Atracurium besylate associated paralysis
besylate associated paralysis
atracurium case paralysis
dipyridamole hyperemia
dipyridamole implications dipyridamole hyperemia
pentoxifylline derivative improve claudication intermittent
pentoxifylline derivative improve claudication
Trental pentoxifylline derivative improve claudication intermittent
Trental pentoxifylline derivative improve claudication
dipyridamole inhibits thallium induced hyperemia
dipyridamole stopped induced hyperemia
dipyridamole hyperemia
dipyridamole induced hyperemia
apomorphine had induced erection penile
apomorphine had induced erection
acetazolamide patients developed calculi renal
acetazolamide patients developed calculi
FK 506 Microangiopathic
FK 506 hemolytic
FK 506 anemia
506 Microangiopathic
506 hemolytic
506 anemia
tacrolimus 506 Microangiopathic
tacrolimus 506 hemolytic
tacrolimus 506 anemia
FK therapy recipients anemia microangiopathic
FK therapy recipients anemia hemolytic
FK therapy recipients anemia
506 therapy recipients anemia microangiopathic
506 therapy recipients anemia hemolytic
506 therapy recipients anemia
FK therapy recipients anemia MAHA
506 therapy recipients anemia MAHA
tacrolimus therapy recipients anemia microangiopathic
tacrolimus therapy recipients anemia hemolytic
tacrolimus therapy recipients anemia
tacrolimus therapy recipients anemia MAHA
FK discontinuation led resolution MAHA
506 FK discontinuation led resolution MAHA
FK reintroduction led recurrence MAHA
506 FK reintroduction led recurrence MAHA
FK associated rare MAHA
506 FK associated rare MAHA
FK 506 seem experience react A immuno drug known induce MAHA
506 seem experience react A immuno drug known induce MAHA
bupivacaine activity modified decreased time convulsions
bupivacaine obtain latency convulsions
paclitaxel stent implantation aneurysm Coronary
paclitaxel stent implantation aneurysm
paclitaxel receiving months developed aneurysm coronary
paclitaxel receiving months developed aneurysm
epinephrine use associated bleeding intracranial
epinephrine use associated bleeding
Epinephrine has role arrest cardiac
Epinephrine has role arrest
oral contraceptives taking woman reported syndrome uremic hemolytic
oral contraceptives taking woman reported syndrome uremic
oral contraceptives taking woman reported syndrome
contraceptives taking woman reported syndrome uremic hemolytic
contraceptives taking woman reported syndrome uremic
contraceptives taking woman reported syndrome
oral contraceptives taking woman reported syndrome HUS
contraceptives taking woman reported syndrome HUS
propofol obtund response hypotensive
propofol ephedrine addition appears method obtunding response hypotensive
propofol obtunding response hypotensive
propofol associated tachycardia
ephedrine use associated tachycardia
propofol use recommend risk tachycardia
ephedrine any patients use recommend risk tachycardia
amphotericin Recurrent failure acute
amphotericin Recurrent failure renal
amphotericin Recurrent failure
amphotericin B administration developed failure acute
amphotericin B administration developed failure renal
amphotericin B administration developed failure
B administration developed failure acute
B administration developed failure renal
B administration developed failure
amphotericin activate contributing failure acute
amphotericin activate contributing failure renal
amphotericin activate contributing failure
epinephrine induced thrombosis
EP epinephrine induced thrombosis
lindane toxic
lindane toxic system to
lindane toxic system the
lindane toxic system central
lindane toxic system nervous
lindane toxic system
lindane toxic accumulating associated anaemia aplastic
lindane toxic accumulating associated anaemia
pilocarpine reported seizures model epilepsy temporal
pilocarpine reported seizures model epilepsy lobe
pilocarpine reported seizures model epilepsy
Lithium associated deficits cognitive
Lithium associated deficits cognitive and
Lithium associated deficits cognitive functional
Lithium associated deficits
lithium effects management written remain effects deficits cognitive
lithium effects management written remain effects deficits
lithium effects management written remain effects deficits loss
lithium effects management written remain effects deficits loss creativity of
lithium effects management written remain effects deficits loss creativity
lithium effects management written remain effects deficits impairments functional
lithium effects management written remain effects deficits impairments
lithium effects deficits cognitive
lithium effects deficits
lithium effects deficits loss
lithium effects deficits loss creativity of
lithium effects deficits loss creativity
lithium effects deficits impairments functional
lithium effects deficits impairments
lithium switching divalproex alleviate impairments cognitive
lithium switching divalproex alleviate impairments cognitive and
lithium switching divalproex alleviate impairments cognitive functional
lithium switching divalproex alleviate impairments
lithium substitution helpful reducing cognitive
lithium substitution helpful reducing cognitive motivational
lithium substitution helpful reducing cognitive or
lithium substitution helpful reducing cognitive deficits creative
lithium substitution helpful reducing cognitive deficits
lithium attributed deficits cognitive
lithium attributed deficits cognitive motivational
lithium attributed deficits cognitive or
lithium attributed deficits creative
lithium attributed deficits
lithium patients experiencing deficits cognitive
lithium patients experiencing deficits
lithium patients experiencing deficits loss
lithium patients experiencing deficits loss creativity of
lithium patients experiencing deficits loss creativity
lithium patients experiencing deficits impairments functional
lithium patients experiencing deficits impairments
Doxorubicin agent known cause cardiomyopathy
lithium Ebstein
lithium Ebstein '
lithium anomaly s
lithium anomaly
cocaine nephritis Henoch related failure acute
cocaine nephritis Henoch related failure renal
cocaine nephritis Henoch related failure
cocaine expression critical induced anxiety
cocaine effects studied paid states anxiety
cocaine induced states anxiety
cocaine examine lack mice performance induced anxiety
cocaine dose anxiety
Cocaine induced attenuated anxiety
cocaine antagonist anxiety
cocaine required indicate induced anxiety
angiotensin introduction converting reported cases hypotension
converting reported cases hypotension
enzyme inhibitors converting reported cases hypotension
ACE inhibitors converting reported cases hypotension
inhibitors converting reported cases hypotension
prazosin multicenter trial designed compared incidence hypotension
ACE enalapril safety assess designed compared incidence hypotension
inhibitor enalapril safety assess designed compared incidence hypotension
prazosin received patients enalapril hypotension
capsaicin induced effects ketamine lidocaine hyperalgesia
capsaicin induced administration hyperalgesia ketamine lidocaine brush pain
capsaicin induced administration hyperalgesia
methamphetamine antagonist action associated decrease hyperthermia
methamphetamine hyperthermia
methamphetamine reduction associated induced induced decrease hyperthermia
DES adenocarcinoma clear
DES adenocarcinoma cell
DES adenocarcinoma
azidothymidine mice anemia
Azidothymidine anemia
AZT Azidothymidine anemia
Phenylephrine reduces
Phenylephrine reduces oxygenation frontal
Phenylephrine reduces oxygenation lobe
Phenylephrine reduces oxygenation
acetaminophen associated deaths apoptotic necrotic
acetaminophen associated induced nephrotoxicity
doxorubicin toxicity amiodarone associated deaths apoptotic necrotic
doxorubicin toxicity amiodarone induced cardiotoxicity
amiodarone associated deaths apoptotic necrotic
amiodarone toxicity lung
amiodarone toxicity
acetaminophen prevent extract proanthocyanidin induced nephrotoxicity
AAP acetaminophen prevent extract proanthocyanidin induced nephrotoxicity
doxorubicin toxicity induced proanthocyanidin induced cardiotoxicity
DOX doxorubicin toxicity induced proanthocyanidin induced cardiotoxicity
amiodarone nephrotoxicity induced proanthocyanidin induced toxicity lung
amiodarone nephrotoxicity induced proanthocyanidin induced toxicity
AMI nephrotoxicity induced proanthocyanidin induced toxicity lung
AMI nephrotoxicity induced proanthocyanidin induced toxicity
AAP induced drugs necrosis
DOX AAP induced drugs necrosis
AMI AAP induced drugs necrosis
nitrendipine nephrosclerosis
nitrendipine treatment effect angiotensin converting pressure albuminuria
nitrendipine treated albuminuria
Perhexiline maleate neuropathy peripheral
Perhexiline maleate neuropathy
maleate neuropathy peripheral
maleate neuropathy
perhexiline maleate noted neuropathy Peripheral
perhexiline maleate noted neuropathy
maleate noted neuropathy Peripheral
maleate noted neuropathy
levodopa Improvement dyskinesia
levodopa improve induced dyskinesia
scopolamine improve decline cognitive
scopolamine improve decline
Valproic acid induced encephalopathy
acid induced encephalopathy
VPA associated effect acid induced encephalopathy
VPA suppression induced encephalopathy
VPA hepatotoxicity induced suppression induced encephalopathy
VPA suppression induced hepatotoxicity
VPA hepatotoxicity
VPA suppression pancreatitis
VPA hepatotoxicity induced suppression pancreatitis
VPA suppression bone
VPA suppression marrow
VPA suppression
VPA hepatotoxicity induced suppression bone
VPA hepatotoxicity induced suppression marrow
VPA hepatotoxicity induced suppression
VPA induced encephalopathy
VPA signs consciousness impaired
VPA signs consciousness
VPA effect proof is patients encephalopathy
VPA patients associated encephalopathy
scopolamine overdosage
hyoscine overdosage
nitrazepam overdose
nitrazepam overdose
chlormethiazole intoxication those two patient conformed coma
nitrazepam overdose patient conformed coma
morphine modulators Effect increase
morphine modulators Effect increase activity in
morphine modulators Effect increase activity locomotor
morphine modulators Effect increase activity
morphine modulators increase
morphine modulators increase activity in
morphine modulators increase activity locomotor
morphine modulators increase activity
morphine kg administration produced increase
morphine kg administration produced activity in
morphine kg administration produced activity locomotor
morphine kg administration produced activity
morphine potentiated hyperactivity
scopolamine potentiated hyperactivity
morphine produced hyperactivity
zonisamide associated hallucinations Visual
zonisamide associated hallucinations
zonisamide treatment begun experienced patients describe reported hallucinations visual
zonisamide treatment begun experienced patients describe reported hallucinations
zonisamide treatment begun experienced hallucinations visual
zonisamide treatment begun experienced hallucinations
midazolam arrest cardiorespiratory
midazolam arrest
midazolam administration associated arrest cardiorespiratory
midazolam administration associated arrest
Phenobarbitone enlargement
Phenobarbitone enlargement liver of
Phenobarbitone enlargement liver the
Phenobarbitone enlargement liver
carbon tetrachloride yield cirrhosis
carbon tetrachloride yield cirrhosis liver of
carbon tetrachloride yield cirrhosis liver the
carbon tetrachloride yield cirrhosis liver
tetrachloride yield cirrhosis
tetrachloride yield cirrhosis liver of
tetrachloride yield cirrhosis liver the
tetrachloride yield cirrhosis liver
carbon tetrachloride dose giving increased primed given yield cirrhosis
carbon tetrachloride dose giving increased primed given yield cirrhosis liver of
carbon tetrachloride dose giving increased primed given yield cirrhosis liver the
carbon tetrachloride dose giving increased primed given yield cirrhosis liver
tetrachloride dose giving increased primed given yield cirrhosis
tetrachloride dose giving increased primed given yield cirrhosis liver of
tetrachloride dose giving increased primed given yield cirrhosis liver the
tetrachloride dose giving increased primed given yield cirrhosis liver
phenobarbitone given induced enlargement
phenobarbitone given induced enlargement liver of
phenobarbitone given induced enlargement liver the
phenobarbitone given induced enlargement liver
phenobarbitone peak giving increased primed given induced enlargement
phenobarbitone peak giving increased primed given induced enlargement liver of
phenobarbitone peak giving increased primed given induced enlargement liver the
phenobarbitone peak giving increased primed given induced enlargement liver
phenobarbitone given yield cirrhosis
phenobarbitone given yield cirrhosis liver of
phenobarbitone given yield cirrhosis liver the
phenobarbitone given yield cirrhosis liver
phenobarbitone peak giving increased primed given yield cirrhosis
phenobarbitone peak giving increased primed given yield cirrhosis liver of
phenobarbitone peak giving increased primed given yield cirrhosis liver the
phenobarbitone peak giving increased primed given yield cirrhosis liver
ceftriaxone induced hepatitis
ceftriaxone induced hepatitis anemia autoimmune
ceftriaxone induced hepatitis anemia hemolytic
ceftriaxone induced hepatitis anemia
ceftriaxone ingesting developed hepatitis
Nimodipine Trial BACKGROUND reduction
Nimodipine Trial BACKGROUND reduction pressure in
Nimodipine Trial BACKGROUND reduction pressure blood
Nimodipine Trial BACKGROUND reduction pressure
nimodipine correlation found Trial BACKGROUND reduction
nimodipine correlation found Trial BACKGROUND reduction pressure in
nimodipine correlation found Trial BACKGROUND reduction pressure blood
nimodipine correlation found Trial BACKGROUND reduction pressure
Nimodipine treatment resulted reduction
Nimodipine treatment resulted reduction BP in
Nimodipine treatment resulted reduction BP systolic
Nimodipine treatment resulted reduction BP
amoxicillin patient case hepatitis
clavulanic acid case hepatitis
acid case hepatitis
amoxicillin patient case hepatitis granulomas
clavulanic acid case hepatitis granulomas
acid case hepatitis granulomas
amiodarone pneumonitis
amiodarone withdrawal need diagnosis pneumonitis
cimetidine patients studies confusion
cimetidine cases reported confusion
bupivacaine develop loss hearing
bupivacaine develop loss
prilocaine given Patients likely develop loss hearing
prilocaine given Patients likely develop loss
bupivacaine dB loss hearing
bupivacaine dB loss
prilocaine dB loss hearing
prilocaine dB loss
risperidone treated subjects observed Drug
risperidone treated subjects observed parkinsonism induced
risperidone treated subjects observed parkinsonism
haloperidol risperidone treated subjects observed Drug
haloperidol risperidone treated subjects observed parkinsonism induced
haloperidol risperidone treated subjects observed parkinsonism
tacrolimus cyclosporine known nephrotoxic
cyclosporine known nephrotoxic
pilocarpine model epilepsy temporal
pilocarpine model epilepsy lobe
pilocarpine model epilepsy
DNR failure heart
DNR failure
5 infusion confusion
fluorouracil confusion
folinic acid fluorouracil confusion
acid fluorouracil confusion
5 lasting coma
fluorouracil infusion lasting coma
5 lasting coma lapsed developed symptoms confusion
fluorouracil infusion lasting coma lapsed developed symptoms confusion
5 lasting coma lapsed developed symptoms confusion disorientation
fluorouracil infusion lasting coma lapsed developed symptoms confusion disorientation
folinic fluorouracil infusion lasting coma
acid infusion lasting coma
folinic fluorouracil infusion lasting coma lapsed developed symptoms confusion
acid infusion lasting coma lapsed developed symptoms confusion
folinic fluorouracil infusion lasting coma lapsed developed symptoms confusion disorientation
acid infusion lasting coma lapsed developed symptoms confusion disorientation
phenacetin comparison use acetaminophen factor failure chronic
phenacetin comparison use acetaminophen factor failure renal
phenacetin comparison use acetaminophen factor failure
phenacetin use associated development failure chronic
phenacetin use associated development failure renal
phenacetin use associated development failure
phenacetin use associated development failure end
phenacetin use associated development failure disease stage
phenacetin use associated development failure disease renal
phenacetin use associated development failure disease
phenacetin use associated development failure disease ESRD
phenacetin contribute burden ESRD
terbutaline treatment abnormalities implications autism
Terbutaline associated concordance autism
ketoconazole treatment complication hypertension
ketoconazole treated syndrome patients Two developed hypertension
ketoconazole therapy achieved demonstrated hypertension
ketoconazole doses treatment induce blockade leading mineralocorticoid hypertension
ribavirin treatment interferon Development myasthenia ocular
ribavirin treatment interferon Development myasthenia
pegylated interferon Development myasthenia ocular
pegylated interferon Development myasthenia
interferon Development myasthenia ocular
interferon Development myasthenia
ribavirin alpha therapy associated myasthenia ocular
ribavirin alpha therapy associated myasthenia
pegylated alpha therapy associated myasthenia ocular
pegylated alpha therapy associated myasthenia
IFN alpha therapy associated myasthenia ocular
IFN alpha therapy associated myasthenia
alpha therapy associated myasthenia ocular
alpha therapy associated myasthenia
2 alpha therapy associated myasthenia ocular
2 alpha therapy associated myasthenia
b alpha therapy associated myasthenia ocular
b alpha therapy associated myasthenia
IFN therapy complications review present reported myasthenia ocular
IFN therapy complications review present reported myasthenia
asenapine % % occurred reported symptoms Extrapyramidal
asenapine % % occurred reported symptoms
haloperidol asenapine % % occurred reported symptoms Extrapyramidal
haloperidol asenapine % % occurred reported symptoms
asenapine similar indicated seen AEs symptoms extrapyramidal
asenapine similar indicated seen AEs symptoms
haloperidol asenapine similar indicated seen AEs symptoms extrapyramidal
haloperidol asenapine similar indicated seen AEs symptoms
cocaine induced seizures
cocaine injection induced seizures
cocaine influences seizures
heparin patients thrombosis
heparin patients thrombosis thrombocytopenia
heparin two antigen thrombosis
heparin concentration characteristics two antigen thrombosis
heparin two antigen thrombocytopenia
heparin two antigen HIT
heparin concentration characteristics two antigen thrombocytopenia
heparin concentration characteristics two antigen HIT
heparin exposure decrease count thrombocytopenia
heparin -RSB- concentration inhibition antigen two had heparin exposure decrease count thrombocytopenia
captopril treatment function deterioration sudden
captopril treatment function deterioration
captopril treatment function of
captopril treatment function renal
captopril treatment function
Levodopa induced dyskinesias
levodopa dyskinesias
levodopa pathophysiology systems preclinical induced dyskinesias
streptozotocin rats membrane associated Reduction induced nephropathy diabetic
streptozotocin rats membrane associated Reduction induced nephropathy
Verapamil withdrawal cause infarction myocardial
Verapamil withdrawal cause infarction
verapamil withdrawal introduction coincided infarction myocardial
verapamil withdrawal introduction coincided infarction
Nitroprusside induced ACTH evokes hypotension
nitroprusside secretion Suppression induced observed hypotension
cyclophosphamide granulomatosis cancer Urinary
cyclophosphamide granulomatosis cancer bladder
cyclophosphamide granulomatosis cancer
cyclophosphamide relation cancer bladder
cyclophosphamide relation cancer
cyclophosphamide bladder
cyclophosphamide cancer
cyclophosphamide = doubled risk cancer bladder
cyclophosphamide = doubled risk cancer
cyclophosphamide relationship dose risk cancer bladder
cyclophosphamide relationship dose risk cancer
alendronate proteinuria
alendronate proteinuria failure acute
alendronate proteinuria failure renal
alendronate proteinuria failure
alendronate sodium administration days increased g failure acute
alendronate sodium administration days increased g failure renal
alendronate sodium administration days increased g failure
sodium administration days increased g failure acute
sodium administration days increased g failure renal
sodium administration days increased g failure
dobutamine detection performance index Assessment induced ischemia myocardial
dobutamine detection performance index Assessment induced ischemia
dobutamine detecting ischemia myocardial
dobutamine detecting ischemia
dobutamine detecting ECG lead assess induced ischemia myocardial
dobutamine detecting ECG lead assess induced ischemia
puromycin aminonucleoside barrier proteins distribution changes nephrosis
aminonucleoside barrier proteins distribution changes nephrosis
puromycin rats nephrosis
aminonucleoside rats nephrosis
isoproterenol severity infarction myocardial
isoproterenol severity infarction
cinacalcet reported nausea headache
cinacalcet desipramine treated patients reported nausea headache
desipramine treatment alone receiving cinacalcet reported nausea
desipramine receiving cinacalcet reported nausea
desipramine treated patients reported nausea
cinacalcet reported nausea
cinacalcet desipramine treated patients reported nausea
desipramine treatment alone receiving cinacalcet reported nausea headache
desipramine receiving cinacalcet reported nausea headache
desipramine treated patients reported nausea headache
Ximelagatran found efficient antagonist withdrawn tests abnormal
Ximelagatran found efficient antagonist withdrawn tests liver
Ximelagatran found efficient antagonist withdrawn tests function
tizanidine initiation Hypotension
lisinopril treated chronically angiotensin converting control hypertension developed hypotension
tizanidine addition hypotension
FK Mechanisms hypertension
506 FK Mechanisms hypertension
FK utility complicated hypertension
506 FK utility complicated hypertension
FK mechanisms clarify hypertension
506 FK mechanisms clarify hypertension
FK effects studied hypertension
506 FK effects studied hypertension
FK FR antagonist studied hypertension
506 FK FR antagonist studied hypertension
FK induced hypertension
506 FK induced hypertension
reserpine hypothermia
d induced hyperactivity
amphetamine d induced hyperactivity
quinpirole amphetamine d induced hyperactivity
TRI increases locomotor induced hyperactivity
heparin enhanced volume hematoma
capsaicin administration induced hyperalgesia
FK 506 consisted vacuolization glomerulosclerosis focal
FK 506 consisted vacuolization glomerulosclerosis segmental
FK 506 consisted vacuolization glomerulosclerosis
506 consisted vacuolization glomerulosclerosis focal
506 consisted vacuolization glomerulosclerosis segmental
506 consisted vacuolization glomerulosclerosis
sulindac therapy associated Hyperkalemia
indomethacin agents complication recognized Hyperkalemia
sulindac administration days developed hyperkalemia
sulindac hyperkalemia
Sulfasalazine induced erythematosus lupus
Sulfasalazine induced erythematosus
sulfasalazine therapy autoantibodies effusions Pneumonitis
sulfasalazine therapy autoantibodies effusions evidence tamponade cardiac
sulfasalazine therapy autoantibodies effusions evidence tamponade
sulfasalazine therapy autoantibodies effusions pleural
sulfasalazine therapy autoantibodies effusions
sulfasalazine lupus
sulfasalazine use Physicians aware lupus
sulfasalazine use Physicians aware lupus syndrome
sulfasalazine signs aware lupus
sulfasalazine signs aware lupus syndrome
metronidazole treatment syndrome Haemolytic
metronidazole treatment syndrome uraemic
metronidazole treatment syndrome
metronidazole developed syndrome haemolytic
metronidazole developed syndrome uraemic
metronidazole developed syndrome
metronidazole aetiology syndrome haemolytic
metronidazole aetiology syndrome uraemic
metronidazole aetiology syndrome
metronidazole involvement established suggest action drug evidence syndrome haemolytic
metronidazole involvement established suggest action drug evidence syndrome uraemic
metronidazole involvement established suggest action drug evidence syndrome
metronidazole involvement established suggest link cases syndrome haemolytic
metronidazole involvement established suggest link cases syndrome uraemic
metronidazole involvement established suggest link cases syndrome
metronidazole treatment link suggest established involvement metronidazole aetiology syndrome haemolytic
metronidazole treatment link suggest established involvement metronidazole aetiology syndrome uraemic
metronidazole treatment link suggest established involvement metronidazole aetiology syndrome
metronidazole treatment link suggest action drug evidence syndrome haemolytic
metronidazole treatment link suggest action drug evidence syndrome uraemic
metronidazole treatment link suggest action drug evidence syndrome
metronidazole treatment link cases syndrome haemolytic
metronidazole treatment link cases syndrome uraemic
metronidazole treatment link cases syndrome
clomiphene associated occlusion retinal
clomiphene associated occlusion vein
clomiphene associated occlusion
clomiphene citrate associated occlusion retinal
clomiphene citrate associated occlusion vein
clomiphene citrate associated occlusion
citrate associated occlusion retinal
citrate associated occlusion vein
citrate associated occlusion
CC citrate associated occlusion retinal
CC citrate associated occlusion vein
CC citrate associated occlusion
CC occlusion vein retinal
CC occlusion vein
CC occlusion
CC courses developed occlusion retinal
CC courses developed occlusion vein
CC courses developed occlusion
CC complications literature search include uncommon disturbance visual
CC complications literature search include uncommon disturbance
CC intake disturbance visual
CC intake disturbance
CC occlusion vein retinal
CC occlusion vein
CC occlusion
Dapsone associated anemia hemolytic
Dapsone associated anemia
dapsone dose taking developed anemia hemolytic
dapsone dose taking developed anemia
dapsone cause anemia hemolytic
dapsone cause anemia
doxorubicin kinase inducible induced syndrome nephrotic
doxorubicin kinase inducible induced syndrome
Doxorubicin treatment resulted 44 mice leading ascites
Doxorubicin treatment resulted proteinuria
Doxorubicin treatment resulted 44 mice leading ascites hypoalbuminemia
Doxorubicin treatment resulted 44 mice leading syndrome nephrotic
Doxorubicin treatment resulted 44 mice leading syndrome
Doxorubicin treatment resulted 44 mice leading ascites lipidemia
atazanavir simvastatin use secondary failure rhabdomyolysis
atazanavir simvastatin use secondary failure rhabdomyolysis acute
atazanavir simvastatin use secondary failure renal
atazanavir simvastatin use secondary failure
amiodarone simvastatin use secondary failure rhabdomyolysis
simvastatin use secondary failure rhabdomyolysis acute
simvastatin use secondary failure renal
simvastatin use secondary failure
simvastatin use secondary failure rhabdomyolysis
amiodarone simvastatin use secondary failure rhabdomyolysis acute
amiodarone simvastatin use secondary failure renal
amiodarone simvastatin use secondary failure
atazanavir simvastatin resulting failure rhabdomyolysis
atazanavir simvastatin resulting failure rhabdomyolysis acute
atazanavir simvastatin resulting failure renal
atazanavir simvastatin resulting failure
amiodarone simvastatin resulting failure rhabdomyolysis
simvastatin resulting failure rhabdomyolysis acute
simvastatin resulting failure renal
simvastatin resulting failure
simvastatin resulting failure rhabdomyolysis
amiodarone simvastatin resulting failure rhabdomyolysis acute
amiodarone simvastatin resulting failure renal
amiodarone simvastatin resulting failure
simvastatin metabolism inhibit presence increased risk rhabdomyolysis
Sirolimus proteinuria
Sirolimus proteinuria dysfunction renal
Sirolimus proteinuria dysfunction
Sirolimus represents advance prevention rejection nephropathy
sirolimus share designated non drug nephrotoxic
sirolimus associated dysfunction proteinuria
sirolimus mechanisms multifactorial proteinuria
sirolimus effects knowledge minimised close monitoring function proteinuria
sirolimus effects knowledge minimised use occurs proteinuria
sirolimus use kidney sirolimus effects knowledge minimised close monitoring function proteinuria
sirolimus use kidney sirolimus effects knowledge minimised use occurs proteinuria
coniine failed produce arthrogryposis
nicotine sulfate occurred hemorrhage cranial
nicotine sulfate occurred hemorrhage
coniine model arthrogryposis
Clomipramine exposure hoarding
Clomipramine exposure include anxiety
Clomipramine exposure include anxiety impairment memory
Clomipramine exposure include anxiety impairment
hydralazine induced hypotension
nitroglycerin hydralazine induced hypotension
Glyburide induced hepatitis
glyburide exist sulfonylurea reports hepatotoxicity
glyburide therapy initiation developed syndrome acute
glyburide therapy initiation developed syndrome hepatitis
glyburide therapy initiation developed syndrome like
glyburide therapy initiation developed syndrome
Glyburide produce hepatitis acute
Glyburide produce hepatitis
Glyburide produce illness like
Glyburide produce illness
N aspirin administration co carcinomas induction tumors forestomach
N aspirin administration co carcinomas induction tumors
-LSB- administration co carcinomas induction tumors forestomach
-LSB- administration co carcinomas induction tumors
4 -LSB- administration co carcinomas induction tumors forestomach
4 -LSB- administration co carcinomas induction tumors
5 -LSB- administration co carcinomas induction tumors forestomach
5 -LSB- administration co carcinomas induction tumors
nitro 5 -LSB- administration co carcinomas induction tumors forestomach
nitro 5 -LSB- administration co carcinomas induction tumors
2 nitro 5 -LSB- administration co carcinomas induction tumors forestomach
2 nitro 5 -LSB- administration co carcinomas induction tumors
furyl 2 nitro 5 -LSB- administration co carcinomas induction tumors forestomach
furyl 2 nitro 5 -LSB- administration co carcinomas induction tumors
2 administration co carcinomas induction tumors forestomach
2 administration co carcinomas induction tumors
thiazolyl -RSB- 2 administration co carcinomas induction tumors forestomach
thiazolyl -RSB- 2 administration co carcinomas induction tumors
-RSB- 2 administration co carcinomas induction tumors forestomach
-RSB- 2 administration co carcinomas induction tumors
formamide administration co carcinomas induction tumors forestomach
formamide administration co carcinomas induction tumors
FANFT formamide administration co carcinomas induction tumors forestomach
FANFT formamide administration co carcinomas induction tumors
FANFT incidence resulted administration co carcinomas induction tumors forestomach
FANFT incidence resulted administration co carcinomas induction tumors
N aspirin administration co carcinomas bladder
N aspirin administration co carcinomas
-LSB- administration co carcinomas bladder
-LSB- administration co carcinomas
4 -LSB- administration co carcinomas bladder
4 -LSB- administration co carcinomas
5 -LSB- administration co carcinomas bladder
5 -LSB- administration co carcinomas
nitro 5 -LSB- administration co carcinomas bladder
nitro 5 -LSB- administration co carcinomas
2 nitro 5 -LSB- administration co carcinomas bladder
2 nitro 5 -LSB- administration co carcinomas
furyl 2 nitro 5 -LSB- administration co carcinomas bladder
furyl 2 nitro 5 -LSB- administration co carcinomas
2 administration co carcinomas bladder
2 administration co carcinomas
thiazolyl -RSB- 2 administration co carcinomas bladder
thiazolyl -RSB- 2 administration co carcinomas
-RSB- 2 administration co carcinomas bladder
-RSB- 2 administration co carcinomas
formamide administration co carcinomas bladder
formamide administration co carcinomas
FANFT formamide administration co carcinomas bladder
FANFT formamide administration co carcinomas
FANFT incidence resulted administration co carcinomas bladder
FANFT incidence resulted administration co carcinomas
amphotericin nephrotoxicity
B nephrotoxicity
amphotericin B potential nephrotoxic
B potential nephrotoxic
nicotine mg caused locomotor significantly lesions operated induced hyperactivity
nicotine enhanced operated induced hyperactivity
morphine antinociception constipation
morphine combination effects constipating
morphine inhibited suggesting develop effects constipating
morphine produced constipation
morphine potentiate suggesting produced constipation
adriamycin -LSB- induced proteinuria
adriamycin elicited proteinuria
adriamycin correlated rise proteinuria
carbimazole reactivity hepatitis Toxic
carbimazole reactivity hepatitis
carbimazole hepatitis
carbimazole mixed cholestatic
carbimazole replaced appeared hepatitis
alprazolam patients developed reactions memory impaired
alprazolam patients developed reactions memory
alprazolam patients developed reactions depression
alprazolam patients developed reactions memory ataxia
alprazolam patients developed reactions depression enuresis
alprazolam patients developed reactions memory loss weight
alprazolam patients developed reactions memory loss
mepivacaine 850 block performance mg observed increase
mepivacaine 850 block performance mg observed increase pressure in
mepivacaine 850 block performance mg observed increase pressure blood
mepivacaine 850 block performance mg observed increase pressure
adrenaline containing mg observed increase
adrenaline containing mg observed increase pressure in
adrenaline containing mg observed increase pressure blood
adrenaline containing mg observed increase pressure
mepivacaine 850 block performance mg observed increase accompanied fibrillation atrial
mepivacaine 850 block performance mg observed increase accompanied fibrillation
adrenaline containing mg observed increase accompanied fibrillation atrial
adrenaline containing mg observed increase accompanied fibrillation
epinephrine hydrocortisone dipyridamole Effects induced injury myocardial
epinephrine hydrocortisone dipyridamole Effects induced injury
epinephrine infusion injury myocardial
epinephrine infusion injury
sumatriptan use sensations Atypical
sumatriptan use sensations
Clonidine bradycardia
1 exposure had workers investigated epidemic disease liver
1 exposure had workers investigated epidemic disease
chloro - 1 exposure had workers investigated epidemic disease liver
chloro - 1 exposure had workers investigated epidemic disease
- 1 exposure had workers investigated epidemic disease liver
- 1 exposure had workers investigated epidemic disease
1 - 1 exposure had workers investigated epidemic disease liver
1 - 1 exposure had workers investigated epidemic disease
2 - 1 exposure had workers investigated epidemic disease liver
2 - 1 exposure had workers investigated epidemic disease
2 - 1 exposure had workers investigated epidemic disease liver
2 - 1 exposure had workers investigated epidemic disease
2 - 1 exposure had workers investigated epidemic disease liver
2 - 1 exposure had workers investigated epidemic disease
tetrafluoroethane - 1 exposure had workers investigated epidemic disease liver
tetrafluoroethane - 1 exposure had workers investigated epidemic disease
HCFC tetrafluoroethane - 1 exposure had workers investigated epidemic disease liver
HCFC tetrafluoroethane - 1 exposure had workers investigated epidemic disease
124 HCFC tetrafluoroethane - 1 exposure had workers investigated epidemic disease liver
124 HCFC tetrafluoroethane - 1 exposure had workers investigated epidemic disease
1 mixture exposure had workers investigated epidemic disease liver
1 mixture exposure had workers investigated epidemic disease
1 exposure had workers investigated epidemic disease liver
1 exposure had workers investigated epidemic disease
dichloro - 1 exposure had workers investigated epidemic disease liver
dichloro - 1 exposure had workers investigated epidemic disease
- 1 exposure had workers investigated epidemic disease liver
- 1 exposure had workers investigated epidemic disease
2 - 1 exposure had workers investigated epidemic disease liver
2 - 1 exposure had workers investigated epidemic disease
2 - 1 exposure had workers investigated epidemic disease liver
2 - 1 exposure had workers investigated epidemic disease
2 - 1 exposure had workers investigated epidemic disease liver
2 - 1 exposure had workers investigated epidemic disease
trifluoroethane exposure had workers investigated epidemic disease liver
trifluoroethane exposure had workers investigated epidemic disease
HCFC 123 trifluoroethane exposure had workers investigated epidemic disease liver
HCFC 123 trifluoroethane exposure had workers investigated epidemic disease
123 trifluoroethane exposure had workers investigated epidemic disease liver
123 trifluoroethane exposure had workers investigated epidemic disease
levodopa administration caused epilepsy
/ administration caused epilepsy
carbidopa administration caused epilepsy
losartan administration anuria
losartan administration developed episodes anuria
losartan mg dose resulted anuria
losartan prescribed developed episode anuria
sodium anticoagulant resulting hypocalcemia
citrate anticoagulant resulting hypocalcemia
citrate due prevent help recommended screening medications conditions predisposing hypocalcemia
omeprazole use associated anemia Hemolytic
omeprazole use associated anemia
omeprazole use reaction anemia hemolytic
omeprazole use reaction anemia
omeprazole starting days developed weakness lethargy
omeprazole starting days developed weakness shortness
omeprazole starting days developed weakness breath of
omeprazole starting days developed weakness breath
omeprazole caused anemia hemolytic
omeprazole caused anemia
beta selected carboline sensitive seizures
carboline sensitive seizures
methyl beta injection resistance seizures
beta injection resistance seizures
carboline injection resistance seizures
3 carboline injection resistance seizures
carboxylate injection resistance seizures
beta carboxylate injection resistance seizures
CCM beta carboxylate injection resistance seizures
picrotoxin states recording induced plus induced diazepam induced seizures
pentylenetetrazol picrotoxin states recording induced plus induced diazepam induced seizures
lopinavir related dilated
lopinavir related cardiomyopathy
ritonavir therapy agent lopinavir related dilated
ritonavir therapy agent lopinavir related cardiomyopathy
lopinavir related dilated developed block heart
lopinavir related dilated developed block
ritonavir therapy agent lopinavir related dilated developed block heart
ritonavir therapy agent lopinavir related dilated developed block
lopinavir agent developed bradycardia
ritonavir therapy agent developed bradycardia
2 injection chloroprocaine CE limb paralysis
chloroprocaine CE limb paralysis
CE limb paralysis
2 received animals cords showed necrosis subpial
2 received animals cords showed necrosis
chloroprocaine showed necrosis subpial
chloroprocaine showed necrosis
CE showed necrosis subpial
CE showed necrosis
nitric hypertension
oxide hypertension
NO synthesis Inhibition induces hypertension
NO ATPase response induced hypertension
NO rats induced hypertension
NO Inhibition synthase induced hypertension
amiodarone treatment occurring block presented intra
amiodarone treatment occurring block Hisian
amiodarone treatment occurring block
cocaine users sleepiness daytime
cocaine users sleepiness
cocaine users decreases sleepiness daytime
cocaine users decreases sleepiness
cocaine use related incidence increasing indicate exceeds that infarction cerebral
cocaine use related incidence increasing indicate exceeds that infarction
cocaine - indicate exceeds that infarction cerebral
cocaine - indicate exceeds that infarction
cocaine administration route follow indicate exceeds that infarction cerebral
cocaine administration route follow indicate exceeds that infarction
cocaine use associated indicate exceeds that infarction cerebral
cocaine use associated indicate exceeds that infarction
cocaine 5 stroke exceeds that infarction cerebral
cocaine 5 stroke exceeds that infarction
isoproterenol detection mTc induced infarction myocardial
isoproterenol detection mTc induced infarction
isoproterenol rats study used easy mTc induced infarction myocardial
isoproterenol rats study used easy mTc induced infarction
estrogen microscopic prolactinomas
estrogen applied clarify cells prolactinoma
estrogen applied induced h cells prolactinoma
venlafaxine overdose
venlafaxine overdose resulting Seizure
venlafaxine overdose
venlafaxine overdose
venlafaxine experienced seizure
venlafaxine overdose
venlafaxine overdose case resulted seizure
venlafaxine overdose
venlafaxine overdose patient resulted episode seizure
prednisolone administration occurred enlargement wastage muscle
prednisolone administration occurred enlargement wastage
prednisolone administration occurred enlargement Liver
prednisolone administration occurred enlargement
ketoconazole ingestion developed weakness extremities tremor
ketoconazole ingestion developed weakness
ketoconazole ingestion developed weakness extremities of
ketoconazole ingestion developed weakness extremities
ketoconazole ingestion developed weakness extremities paralysis legs
ketoconazole ingestion developed weakness extremities paralysis
ketoconazole ingestion developed weakness extremities dysarthria
gentamicin induced failure acute
gentamicin induced failure renal
gentamicin induced failure
GM gentamicin induced failure acute
GM gentamicin induced failure renal
GM gentamicin induced failure
gum rats treatment effect assessed Arabic failure acute
gum rats treatment effect assessed Arabic failure renal
gum rats treatment effect assessed Arabic failure
Arabic failure acute
Arabic failure renal
Arabic failure
tacrolimus Recovery associated neuritis brachial
tacrolimus Recovery associated neuritis
levofloxacin warfarin interaction result appear cases complications bleeding
warfarin interaction result appear cases complications bleeding
aminophylline threshold initiating fibrillation ventricular
aminophylline threshold initiating fibrillation
aminophylline threshold ventricular
aminophylline threshold fibrillation
aminophylline infusion reduced threshold ventricular
aminophylline infusion reduced threshold fibrillation
aminophylline infusion resulted decrease threshold ventricular
aminophylline infusion resulted decrease threshold fibrillation
tAMCA retains action convulsive
tAMCA caused activity associated behaviours convulsive
tAMCA concentration increased degree seizures
tAMCA evoked seizures generalized
tAMCA evoked seizures
tAMCA evoked mg correlated potentials convulsive
tAMCA concentration evoked evoked seizures generalized
tAMCA concentration evoked evoked seizures
tAMCA concentration evoked evoked mg correlated potentials convulsive
Tranexamic acid retains action convulsive
acid retains action convulsive
octreotide analog function formation gallstone
octreotide treatment had gallstones
octreotide treatment had developed cholecystitis acute
octreotide treatment had developed cholecystitis
octreotide patients gallstones
octreotide therapy cholecystitis sludge gallstones
timolol 0 treated % h diagnosed suffering depression
timolol treatment patients presented values depression
timolol inducer less depression
Triazolam induced episodes mania
triazolam doses induced episodes mania
triazolam action duration coincident excitement Manic
pilocarpine induced epilepsy
suxamethonium doses Comparison bradycardia
suxamethonium doses arrhythmia bradycardia
Sulpiride induced dystonia tardive
Sulpiride induced dystonia
sulpiride therapy starting developed dystonia
sulpiride reports dystonia tardive
sulpiride reports dystonia
amphotericin related dilated
amphotericin related cardiomyopathy
B therapy amphotericin related dilated
B therapy amphotericin related cardiomyopathy
amphotericin B developed cardiomyopathy failure heart
amphotericin B developed cardiomyopathy failure
B developed cardiomyopathy failure heart
B developed cardiomyopathy failure
AmB B developed cardiomyopathy failure heart
AmB B developed cardiomyopathy failure
amphotericin B developed cardiomyopathy dilated
amphotericin B developed cardiomyopathy
B developed cardiomyopathy dilated
B developed cardiomyopathy
AmB B developed cardiomyopathy dilated
AmB B developed cardiomyopathy
AmB substituted abnormalities failure heart
AmB substituted abnormalities failure
Cocaine induced infarction myocardial
Cocaine induced infarction
cocaine result infarction acute
cocaine result infarction myocardial
cocaine result infarction
cocaine associated demand result infarction acute
cocaine associated demand result infarction myocardial
cocaine associated demand result infarction
Verapamil induced neurotoxicity
carbamazepine induced neurotoxicity
verapamil treatment neurotoxicity
carbamazepine neurotoxicity
methylphenidate intake vasculitis Cerebral
methylphenidate intake vasculitis
methylphenidate intake reported documented vasculitis Cerebral
methylphenidate intake reported documented vasculitis
valproic acid reaction Confusion
acid reaction Confusion
valproic acid observed reaction Confusion
acid observed reaction Confusion
valproic acid reported cases confusion
acid reported cases confusion
valproic acid reported confusion
acid reported confusion
valproic exposure weeks occurred Confusion
acid exposure weeks occurred Confusion
valproic acid confusion
acid confusion
D treatment globulin induced anemia aplastic
D treatment globulin induced anemia
penicillamine globulin induced anemia aplastic
penicillamine globulin induced anemia
D due therapy anemia aplastic
D due therapy anemia
penicillamine therapy described patient received due therapy anemia aplastic
penicillamine therapy described patient received due therapy anemia
D induced anemia aplastic
D induced anemia
penicillamine D induced anemia aplastic
penicillamine D induced anemia
adriamycin nephrosis
adriamycin dose given divided groups matched albuminuria
adriamycin nephrosis
sulphasalazine course day developed constellation dermatitis hepatitis
sulphasalazine course day developed constellation dermatitis lymphadenopathy
sulphasalazine course day developed constellation dermatitis
sulphasalazine course day developed constellation dermatitis fever
levodopa dyskinesias
Levodopa induced present dyskinesias
Levodopa induced present dyskinesias LIDs
MPTP types Using parkinsonism
levodopa therapy duration progression rate involved development LIDs
levodopa therapy onset exposure Monkeys developed dyskinesia
levodopa administration days dyskinesia
levodopa therapy duration monkeys resistant LIDs
levodopa therapy duration monkeys resistant LIDs e developed dyskinesia
levodopa administration e LIDs
levodopa administration e developed dyskinesia
levodopa develop LIDs
levodopa develop demonstrate studying pathophysiology LIDs
verapamil induced bradycardia
dipyridamole administration occurred Angina
levodopa effect hypotensive
levodopa mechanism hypotensive
riboflavin thiamine deficiency common neuropathy Peripheral
riboflavin thiamine deficiency common neuropathy
riboflavin thiamine deficiency common neuropathy presented neuropathy sensory sensori
riboflavin thiamine deficiency common neuropathy presented neuropathy motor
riboflavin thiamine deficiency common neuropathy presented neuropathy
thiamine deficiency common neuropathy Peripheral
thiamine deficiency common neuropathy
thiamine deficiency common neuropathy presented neuropathy sensory sensori
thiamine deficiency common neuropathy presented neuropathy motor
thiamine deficiency common neuropathy presented neuropathy
vitamin doses D 5 x associated hypercalcemia hyperphosphatemia
D 5 x associated hypercalcemia hyperphosphatemia
3 D 5 x associated hypercalcemia hyperphosphatemia
vitamin D 10 associated hypercalcemia hyperphosphatemia
D 10 associated hypercalcemia hyperphosphatemia
3 D 10 associated hypercalcemia hyperphosphatemia
vitamin 3 increases hypercalcemia hyperphosphatemia
D 3 increases hypercalcemia hyperphosphatemia
3 increases hypercalcemia hyperphosphatemia
vitamin doses D 5 x associated hypercalcemia
D 5 x associated hypercalcemia
3 D 5 x associated hypercalcemia
vitamin D 10 associated hypercalcemia
D 10 associated hypercalcemia
3 D 10 associated hypercalcemia
vitamin 3 increases hypercalcemia
D 3 increases hypercalcemia
3 increases hypercalcemia
adriamycin cardiotoxicity
adriamycin effects cardiotoxic
Capsaicin applied increases
Capsaicin applied flow in
Capsaicin applied flow dural
Capsaicin applied flow dural and
Capsaicin applied flow dural cortical
Capsaicin applied flow blood
Capsaicin applied flow
Thyroxine abuse case thyrotoxicosis
thyroxine abuse considered remains cause thyrotoxicosis
ketoconazole treatment associated deaths two continued onset symptoms hepatitis
ketoconazole treatment associated deaths two continued onset symptoms jaundice
ketoconazole treatment advised monitoring intervals evidence hepatitis
ketoconazole treatment advised prevent injury hepatic
ketoconazole treatment advised prevent injury
phenylephrine labeled quantitated induced hypertension
Ketoconazole induced torsades
Ketoconazole induced torsades pointes de
Ketoconazole induced torsades pointes
ketoconazole taking developed torsades
ketoconazole taking developed pointes de
ketoconazole taking developed pointes
ketoconazole taking developed pointes TdP
ketoconazole taking developed interval prolonged
ketoconazole taking developed interval QT
ketoconazole taking developed interval
ketoconazole prolong induce TdP
ketoconazole administered patients factors syndrome long
ketoconazole administered patients factors syndrome QT
ketoconazole administered patients factors syndrome
Nitroglycerin shown reduce ST induced hypotension
nitroglycerin reverse agents potentiated elevation ST induced hypotension
zidovudine suppression bone
zidovudine suppression marrow
zidovudine suppression
ZDV zidovudine suppression bone
ZDV zidovudine suppression marrow
ZDV zidovudine suppression
ZDV therapy supplementation 12 seem B induced myelotoxicity
ZDV induced myelotoxicity
phenytoin patients cerebellum volumetry overdosages
phenytoin overdosage
phenytoin medication cause unlikely conclude result overdosage
capsaicin intensity modulation induced hyperalgesia
capsaicin attention affected hyperalgesia
capsaicin that similar magnitude modulation hyperalgesia
capsaicin treatment interaction suggest capsaicin induced hyperalgesia
capsaicin induced hyperalgesia
sirolimus switch proteinuria
sirolmus lacks reported proteinuria
Srl sirolmus lacks reported proteinuria
Srl associated proteinuria
Srl associated proteinuria
Srl develop proteinuria
Srl used monitored proteinuria
scopolamine test induced amnesia
dicyclomine scopolamine test induced amnesia
Suxamethonium infusion fasciculations
co exams formation cases patients developed cholestasis intrahepatic
co exams formation cases patients developed cholestasis
trimoxazole treatment formation cases patients developed cholestasis intrahepatic
trimoxazole treatment formation cases patients developed cholestasis
apraclonidine significant effects ocular
apraclonidine significant effects hypotensive
apraclonidine administration significant treated significant effects ocular
apraclonidine administration significant treated significant effects hypotensive
puromycin aminonucleoside subunit syndrome nephrotic
puromycin aminonucleoside subunit syndrome
aminonucleoside subunit syndrome nephrotic
aminonucleoside subunit syndrome
puromycin aminonucleoside syndrome nephrotic
puromycin aminonucleoside syndrome
aminonucleoside syndrome nephrotic
aminonucleoside syndrome
PAN aminonucleoside syndrome nephrotic
PAN aminonucleoside syndrome
PAN dose treated studied courses excretion proteinuria
PAN model phase syndrome nephrotic
PAN model phase syndrome
sirolimus administration proteinuria
sirolimus use linked proteinuria
sirolimus use associated proteinuria
sirolimus therapy proteinuria
sirolimus therapy commencement association implicated etiology proteinuria
sirolimus implicated association commencement therapy proteinuria
sirolimus implicated etiology proteinuria
sirolimus initiation association proteinuria
sirolimus therapy correlated Proteinuria
sirolimus discontinuation resulted decrease proteinuria
Sirolimus induces pre proteinuria
sirolimus withdrawn improve Proteinuria
tacrolimus receiving patients groups compared period year group comprising patients hypertensive
tacrolimus associated nephrotoxicity reducing nifedipine recipients impact factor selecting agent treat hypertension
Fluoxetine induced akathisia
fluoxetine receiving patients developed akathisia
fluoxetine purposeless indistinguishable akathisia
fluoxetine symptoms identical reported akathisia
fluoxetine akathisia
fluoxetine effect appeared Akathisia
fluoxetine akathisia
fluoxetine caused identical pathophysiology jitteriness akathisia
fluoxetine jitteriness pathophysiology identical caused fluoxetine akathisia
fluoxetine jitteriness akathisia
verapamil ablation induced tachycardia atrioventricular
verapamil ablation induced tachycardia reentrant
verapamil ablation induced tachycardia
verapamil block caused QRS established attack AVRT
prochlorperazine administration infusion affect incidence akathisia
prochlorperazine administration compare rate akathisia
prochlorperazine administered reduction incidence akathisia
Ceftriaxone associated pseudolithiasis biliary
Ceftriaxone associated pseudolithiasis
ceftriaxone leads pseudolithiasis
ceftriaxone treatment receiving patients evaluated importance pseudolithiasis
clonidine induces withdrawal bradycardia
clonidine effects hypothesized exhibits given induces withdrawal bradycardia
clonidine rate induced bradycardia
nitroprusside CPAP shunt hypotension
nitroprusside infusion produced decrease
nitroprusside infusion produced pressure in
nitroprusside infusion produced pressure arterial
nitroprusside infusion produced pressure blood
nitroprusside infusion produced pressure
Nitroprusside caused decreases
Nitroprusside caused pressure in
Nitroprusside caused pressure arterial
Nitroprusside caused pressure blood
Nitroprusside caused pressure
ribavirin has managed anemia
neostigmine nicotine induced endpoints convulsion
carbachol nicotine induced endpoints convulsion
nicotine induced endpoints convulsion
flunitrazepam injection pain
cisplatin nephrotoxicity
pilocarpine evoked epilepticus status
pilocarpine evoked epilepticus
pilocarpine evoked Infarcts
pilocarpine evoked Infarcts reticulata in
pilocarpine evoked Infarcts reticulata substantia
pilocarpine evoked Infarcts reticulata nigra
pilocarpine evoked Infarcts reticulata pars
pilocarpine evoked Infarcts reticulata
creatine supplementation associated fibrillation atrial
creatine supplementation associated fibrillation
paclitaxel neurotoxicity peripheral
paclitaxel neurotoxicity
paclitaxel chemotherapy factor neuropathy peripheral
paclitaxel chemotherapy factor neuropathy
PAC paclitaxel chemotherapy factor neuropathy peripheral
PAC paclitaxel chemotherapy factor neuropathy
PAC ameliorate claimed factor neuropathy peripheral
PAC ameliorate claimed factor neuropathy
PAC preventing evaluate aimed induced neuropathy peripheral
PAC preventing evaluate aimed induced neuropathy
PAC neurotoxicity peripheral
PAC neurotoxicity
smoking influence estimated associated loss hearing
smoking influence estimated associated loss
smoking associated loss hearing
smoking associated loss
Suxamethonium induced arrest cardiac
Suxamethonium induced arrest
suxamethonium use hyperkalaemia result death case arrest cardiac
suxamethonium use hyperkalaemia result death case arrest
suxamethonium use hyperkalaemia
suxamethonium arrest cardiac
suxamethonium arrest
suxamethonium bradycardia
suxamethonium administration hyperkalaemia
suxamethonium caused hypersensitivity
bromocriptine isoproterenol pretreatment Effects tachycardia
bromocriptine shown mediated tachycardia
bromocriptine tachycardia
Isoproterenol pretreatment caused hypertrophy cardiac
Isoproterenol pretreatment caused hypertrophy
bromocriptine induced hypotension
bromocriptine induced hypotension tachycardia
Bromocriptine induced unaffected hypotension
isoproterenol pretreatment unaffected reversed bradycardia
Bromocriptine induced unaffected reversed tachycardia
domperidone i reduced effect bradycardia
isoproterenol pretreatment abolished 15 induced bradycardia
bromocriptine reversed abolished 15 induced tachycardia
bromocriptine tachycardia
CaCl induced aneurysm thoracic
CaCl induced aneurysm aortic
CaCl induced aneurysm
2 CaCl induced aneurysm thoracic
2 CaCl induced aneurysm aortic
2 CaCl induced aneurysm
calcium chloride establish model aneurysm thoracic
calcium chloride establish model aneurysm aortic
calcium chloride establish model aneurysm
chloride establish model aneurysm thoracic
chloride establish model aneurysm aortic
chloride establish model aneurysm
calcium chloride establish model aneurysm TAA
chloride establish model aneurysm TAA
calcium chloride establish designed explore formation TAA
chloride establish designed explore formation TAA
CaCl chloride establish model aneurysm thoracic
CaCl chloride establish model aneurysm aortic
CaCl chloride establish model aneurysm
2 NNS chloride establish model aneurysm thoracic
2 NNS chloride establish model aneurysm aortic
2 NNS chloride establish model aneurysm
CaCl chloride establish model aneurysm TAA
2 NNS chloride establish model aneurysm TAA
CaCl chloride establish designed explore formation TAA
2 NNS chloride establish designed explore formation TAA
CaCl establishes model TAA
2 exposure CaCl establishes model TAA
sorafenib sunitinib inhibitors number found cause hemolysis
sunitinib inhibitors number found cause hemolysis
capsaicin components memory pain
capsaicin doses injections received address long memory pain
capsaicin doses able magnitude pain
penicillamine therapy caused gravis Myasthenia
penicillamine therapy caused gravis
chloroquine penicillamine therapy caused gravis Myasthenia
chloroquine penicillamine therapy caused gravis
penicillamine therapy had gravis myasthenia
penicillamine therapy had gravis
chloroquine penicillamine therapy had gravis myasthenia
chloroquine penicillamine therapy had gravis
delta induced involvement catalepsy
9 delta induced involvement catalepsy
tetrahydrocannabinol delta induced involvement catalepsy
haloperidol induced catalepsy important have role manifestation catalepsy
haloperidol induced catalepsy
THC induced catalepsy
THC induced catalepsy manifestation role have important catalepsy
Lithium seems polyuria
ticlopidine developed treatment jaundice
ticlopidine mechanisms unclear cholestasis
oral contraceptives use thromboembolism venous
oral contraceptives use thromboembolism
contraceptives use thromboembolism venous
contraceptives use thromboembolism
oral contraceptives associated thromboembolism venous
oral contraceptives associated thromboembolism
contraceptives associated thromboembolism venous
contraceptives associated thromboembolism
oral contraceptives associated thromboembolism VTE
contraceptives associated thromboembolism VTE
OC contraceptives associated thromboembolism venous
OC contraceptives associated thromboembolism
OC contraceptives associated thromboembolism VTE
OC use patterns distinguish risk thromboembolism venous
OC use patterns distinguish risk thromboembolism
OC use patterns distinguish risk thromboembolism VTE
OC users VTE
methylprednisolone administration CONCLUSIONS related incidence effects nausea
methylprednisolone administration CONCLUSIONS related incidence effects nausea vomiting
methylprednisolone administration CONCLUSIONS related incidence effects nausea headache
gentamicin methylprednisolone administration CONCLUSIONS related incidence effects nausea headache
gentamicin methylprednisolone administration CONCLUSIONS related incidence effects nausea
gentamicin methylprednisolone administration CONCLUSIONS related incidence effects nausea vomiting
capsaicin skin stimulation nociceptive induced gabapentin induced hyperalgesia secondary
capsaicin skin stimulation nociceptive induced gabapentin induced hyperalgesia
amphetamine Protection induced neurotoxicity
amphetamine compounds effect neurotoxic
cyclophosphamide responses characterization cystitis
cyclophosphamide cystitis
lithium feeding Effects failure chronic
lithium feeding Effects failure renal
lithium feeding Effects failure
Lithium caused hypertension proteinuria
Lithium caused hypertension
Li associated proteinuria
Li associated proteinuria hypertension
Capsaicin injected induce pain
phenylpropanolamine infarction Cerebral
phenylpropanolamine infarction
PPA dose taking suffered infarction cerebral
PPA dose taking suffered infarction
appetite suppressants associated incidence hypertension primary
appetite suppressants associated incidence hypertension pulmonary
appetite suppressants associated incidence hypertension
suppressants associated incidence hypertension primary
suppressants associated incidence hypertension pulmonary
suppressants associated incidence hypertension
appetite drugs intake associated disease hypertension Primary
appetite drugs intake associated disease hypertension pulmonary
appetite drugs intake associated disease hypertension
suppressant drugs intake associated disease hypertension Primary
suppressant drugs intake associated disease hypertension pulmonary
suppressant drugs intake associated disease hypertension
appetite suppressants taken patients uncertain diagnosis hypertension primary
appetite suppressants taken patients uncertain diagnosis hypertension pulmonary
appetite suppressants taken patients uncertain diagnosis hypertension
suppressants taken patients uncertain diagnosis hypertension primary
suppressants taken patients uncertain diagnosis hypertension pulmonary
suppressants taken patients uncertain diagnosis hypertension
appetite suppressants prescription policy lead incidence hypertension primary
appetite suppressants prescription policy lead incidence hypertension pulmonary
appetite suppressants prescription policy lead incidence hypertension
suppressants prescription policy lead incidence hypertension primary
suppressants prescription policy lead incidence hypertension pulmonary
suppressants prescription policy lead incidence hypertension
busulfan cystitis
busulfan cystitis appearances radiation cystitis
valproate features encephalopathy
sodium application valproate revealed valproate encephalopathy
valproate revealed valproate encephalopathy
valproate encephalopathy
valproate encephalopathy
sulpiride induced hyperprolactinemia
molindone administration rhabdomyolysis
molindone administration failure acute
molindone administration failure renal
molindone administration failure
molindone administration failure rhabdomyolysis
epinephrine developed stunning myocardial
epinephrine developed stunning
lidocaine sevoflurane effects convulsions
lidocaine influence studied convulsions
lidocaine / was threshold convulsive
lidocaine toxicity effect convulsive
nitroglycerin application sided received patients migraine
nitroglycerin induced attacks migraine
nitroglycerin developed patients migraine
nitroglycerin effect inducing seems migraine
nitroglycerin effect inducing seems suggesting importance development crisis migraine
cocaine LR mice treatment pre induced convulsions
cocaine effects anti ligands involved validate shown attenuate effects convulsive
cocaine effects convulsive
isoproterenol A effect infarction myocardial
isoproterenol A effect infarction
isoproterenol induced infarction myocardial
isoproterenol induced infarction
isoproterenol induced infarction myocardial
isoproterenol induced infarction
diazepam greater impaired
diazepam greater impaired recall immediate
diazepam greater impaired recall free
diazepam greater impaired recall
propranolol greater impaired
propranolol greater impaired recall immediate
propranolol greater impaired recall free
propranolol greater impaired recall
flutamide intramuscularly -RSB- evaluated anemia
leuprolide acetate 3 -RSB- evaluated anemia
acetate 3 -RSB- evaluated anemia
LHRH acetate 3 -RSB- evaluated anemia
A LHRH acetate 3 -RSB- evaluated anemia
alpha mg methyldopa effect hypotensive
methyldopa effect hypotensive
hepatitis reactivation hepatitis
hepatitis reactivation B
B antigen Lamivudine prevention reactivation hepatitis
B antigen Lamivudine prevention reactivation B
surface antigen Lamivudine prevention reactivation hepatitis
surface antigen Lamivudine prevention reactivation B
antigen Lamivudine prevention reactivation hepatitis
antigen Lamivudine prevention reactivation B
HBSAG antigen Lamivudine prevention reactivation hepatitis
HBSAG antigen Lamivudine prevention reactivation B
Ranitidine induced nephritis interstitial
Ranitidine induced nephritis
ranitidine case nephritis interstitial
ranitidine case nephritis
Propylthiouracil induced staining pericarditis
propylthiouracil case describe induced vasculitis manifesting pericarditis
propylthiouracil developed syndrome pericarditis fever
propylthiouracil developed syndrome pericarditis
propylthiouracil developed syndrome pericarditis glomerulonephritis
propylthio associated vasculitis pANCA uracil revealed reports pericarditis
uracil revealed reports pericarditis
propylthio attributable induced manifestation Pericarditis
uracil therapy manifestation Pericarditis
Adriamycin induced plays role model failure heart
Adriamycin induced plays role model failure
adriamycin induced failure heart
adriamycin induced failure
adriamycin induced failure heart
adriamycin induced failure
adriamycin induced failure progression involved develop failure heart
adriamycin induced failure progression involved develop failure
adriamycin induced rats model heart
adriamycin induced rats model failure
adriamycin induced rats plays role pathogenesis failure heart
adriamycin induced rats plays role pathogenesis failure
adriamycin caused failure heart
adriamycin caused failure
diethylstilbestrol induced tumors Pituitary
diethylstilbestrol induced tumors
DES diethylstilbestrol induced tumors Pituitary
DES diethylstilbestrol induced tumors
ADR induced alterations cardiac
ADR induced alterations morphological
ADR induced alterations
Cocaine pain chest
Cocaine pain
cocaine produce pain chest
cocaine produce pain
cocaine tendency ought mind faced victim pain chest
cocaine tendency ought mind faced victim pain
cocaine use related pain chest
cocaine use related pain
pentazocine affected muscle due neuropathy compression
pentazocine affected muscle due neuropathy
pentazocine induced myopathy
Paracetamol associated coma acidosis metabolic
Paracetamol associated coma acidosis
paracetamol ingestion failure acidosis metabolic
paracetamol ingestion failure acidosis
D induced angiopathy
penicillamine D induced angiopathy
epinephrine bolus provoked crisis hypertensive
tacrolimus triggered dysfunction resulted dysfunction myopathy
tacrolimus triggered dysfunction resulted dysfunction tubular
tacrolimus triggered dysfunction resulted dysfunction
lamivudine augmented triggered dysfunction resulted dysfunction tubular
lamivudine augmented triggered dysfunction resulted dysfunction
lamivudine augmented triggered dysfunction resulted dysfunction myopathy
Diazepam served amnesia
scopolamine amnesia
diazepam scopolamine induced amnesia
scopolamine induced amnesia
indomethacin therapy pulmonale patient cirrhosis ascites
indomethacin therapy pulmonale reported hyperkalemia
indomethacin therapy pulmonale patient cirrhosis cor
indomethacin therapy pulmonale
indomethacin therapy pulmonale patient cirrhosis
indomethacin dose exposure caused recurrence oliguria
pilocarpine injection rats Similar causes epilepticus status
pilocarpine injection rats Similar causes epilepticus
pilocarpine injection rats Similar causes epilepticus SE
pilocarpine injection rats Similar causes epilepticus development seizures
pilocarpine treated mice experience SE
levodopa hypotension disorders gastrointestinal
levodopa hypotension disorders
levodopa hypotension orthostatic
levodopa hypotension
levodopa psychosis parasomnias
nitroglycerin Provocation hypotension
magnesium administration presenting gravis Myasthenia
magnesium administration presenting gravis
magnesium administration paralysis described patients gravis myasthenia
magnesium administration paralysis described patients gravis
disulfiram intoxication fold vocal
disulfiram intoxication fold
disulfiram intoxication fold palsy
disulfiram overdose caused neuropathy rare is report leading fold vocal
disulfiram overdose caused neuropathy rare is report leading fold
disulfiram overdose caused neuropathy rare is report leading fold palsy
disulfiram overdose caused neuropathy peripheral
disulfiram overdose caused neuropathy
Warfarin induced accelerated calcification artery
Warfarin induced accelerated calcification
Warfarin doses given rats enhance extent calcification artery
Warfarin doses given rats enhance extent calcification
Warfarin calcification artery
Warfarin calcification
Warfarin weeks Treatment caused calcification
Warfarin weeks Treatment caused calcification media of
Warfarin weeks Treatment caused calcification media the
Warfarin weeks Treatment caused calcification media artery
Warfarin treatment weeks detected calcification artery
Warfarin treatment weeks detected calcification
Warfarin growth calcification artery
Warfarin growth calcification
Warfarin groups treatment produced calcification
Warfarin groups treatment produced calcification media of
Warfarin groups treatment produced calcification media the
Warfarin groups treatment produced calcification media artery
Warfarin groups treatment produced calcification rats calcification artery
Warfarin groups treatment produced calcification rats calcification
Warfarin resistant groups either fed levels was determined explanation association calcification artery
Warfarin resistant groups either fed levels was determined explanation association calcification
Warfarin resistant groups either fed levels was calcification artery
Warfarin resistant groups either fed levels was calcification
Warfarin resistant groups either fed levels induced calcification artery
Warfarin resistant groups either fed levels induced calcification
Warfarin increased suggests related calcification artery
Warfarin increased suggests related calcification
Warfarin D synergy examined calcification artery
Warfarin D synergy examined calcification
Warfarin doses known calcification
Warfarin doses known calcification media of
Warfarin doses known calcification media the
Warfarin doses known calcification media artery
Warfarin D treated rats found sites calcification artery
Warfarin D treated rats found sites calcification
sirolimus Proteinuria
sirolimus therapy consequence reported proteinuria
SRL conversion displayed proteinuria
SRL use common proteinuria
DFO reduction submitted Subjects SNHL
amphetamine dose sensitization cross behavioral
amphetamine dose sensitization cross
amphetamine dose sensitization
amphetamine dose sensitization cross behavioral
amphetamine dose sensitization cross
amphetamine dose sensitization
amphetamine hyperactive
amphetamine injection followed libitum groups amphetamine hyperactive
amphetamine injection followed chow injection followed libitum groups amphetamine hyperactive
amphetamine sucrose chow injection followed chow injection followed libitum groups amphetamine hyperactive
sucrose experienced animals hyperactive
sucrose % followed libitum groups amphetamine hyperactive
sucrose chow injection followed chow injection followed libitum groups amphetamine hyperactive
Cocaine use predisposed rupture aneurysmal
Cocaine use predisposed rupture
AraG attributable effects included 2 neuropathy
AraG attributable effects included 2 neuropathy pain musculoskeletal
AraG attributable effects included 2 neuropathy pain
AraG greater toxicity Haematological
AraG greater toxicity
AraG giving safety supports monitored toxicity neurological
AraG giving safety supports monitored toxicity
rilmenidine rats operated elicited hypotension
alpha rilmenidine rats operated elicited hypotension
methyldopa elicited hypotension
rilmenidine effect contrast methyldopa alpha hypotension enhanced response hypotensive
rilmenidine effect contrast methyldopa alpha hypotension
alpha hypotension enhanced response hypotensive
methyldopa alpha hypotension enhanced response hypotensive
alpha hypotension
methyldopa alpha hypotension
alpha hypotension
methyldopa hypotension
alpha interaction hypotension
methyldopa alpha interaction hypotension
sirolimus due proteinuria
sirolimus due remained observed proteinuria
sirolimus therapy observed remained due proteinuria
sirolimus therapy observed proteinuria
sirolimus received patients observed observed remained due proteinuria
sirolimus received patients observed observed proteinuria
Mipafox dosages produced degree damage cord
Mipafox dosages produced degree damage
raloxifene due thromboembolism risk venous
raloxifene due thromboembolism
nicotine receptors induced hyperactivity
Nicotine caused increase
Nicotine caused activity in
Nicotine caused activity locomotor
Nicotine caused activity
Nicotine blocked hyperactivity
nicotine PHNO induced hyperactivity
nicotine injection induces hyperactivity
Suxamethonium induced apnea
Suxamethonium causes apnea
organophosphorus deactivated poisons gets apnea
OP organophosphorus deactivated poisons gets apnea
poisons gets apnea
OP compound attempt information concealed ensued apnea
compound attempt information concealed ensued apnea
isoflurane metabolism flow induced hypotension
isoflurane hypotension
isoflurane dose increasing induced MAP hypotension
Spironolactone induced insufficiency renal
Spironolactone induced insufficiency
Spironolactone induced insufficiency hyperkalemia
spironolactone use evaluating patients reported risk hyperkalemia insufficiency renal
spironolactone use evaluating patients reported risk hyperkalemia insufficiency
spironolactone use evaluating patients reported risk hyperkalemia
spironolactone treated patients determine prevalence associations insufficiency hyperkalemia renal
spironolactone treated patients determine prevalence associations insufficiency
spironolactone treated patients determine prevalence associations insufficiency hyperkalemia
spironolactone failure renal
spironolactone failure
spironolactone hyperkalemia
Spironolactone CONCLUSIONS common hyperkalemia insufficiency renal
Spironolactone CONCLUSIONS common hyperkalemia insufficiency
Spironolactone CONCLUSIONS common hyperkalemia
MDMA users show process impairments coupled processes social impaired
MDMA users show process impairments coupled processes social
MDMA users show process impairments coupled processes social and
MDMA users show process impairments coupled processes social emotional
MDMA users show process impairments coupled processes judgement
MDMA users show process impairments coupled processes
diclofenac induced recorded abnormalities
diclofenac induced recorded abnormalities function of
diclofenac induced recorded abnormalities function liver
diclofenac induced recorded abnormalities function
diclofenac induced hepatitis
haloperidol Effects catalepsy parkinsonian
haloperidol Effects catalepsy
haloperidol pallidus infusions RESULTS catalepsy parkinsonian
haloperidol pallidus infusions RESULTS catalepsy
citalopram adolescent twitching Palpebral
citalopram adolescent twitching
citalopram boy treatment report depression exhibited twitching palpebral
citalopram boy treatment report depression exhibited twitching
cocaine toxicity blockade observed H reduced up seizures
scopolamine produced Amnesia
cycloheximide scopolamine produced Amnesia
scopolamine reversed cycloheximide induced amnesia
scopolamine pre failed reverse amnesia
scopolamine cycloheximide induced amnesia
scopolamine cycloheximide reversed scopolamine pre failed reverse amnesia
cycloheximide induced amnesia
cycloheximide reversed scopolamine pre failed reverse amnesia
cycloheximide amnesia reverse failed pre scopolamine reversed cycloheximide induced amnesia
cycloheximide amnesia
morphine group incidence tachyarrhythmias beats ventricular
morphine group incidence tachyarrhythmias beats ectopic
morphine group incidence tachyarrhythmias beats
puromycin aminonucleoside injection induced urea syndromes proteinuria hypoalbuminemia
aminonucleoside injection induced urea syndromes proteinuria hypoalbuminemia
puromycin aminonucleoside injection induced urea syndromes proteinuria hypercholesterolemia
aminonucleoside injection induced urea syndromes proteinuria hypercholesterolemia
puromycin aminonucleoside injection induced urea syndromes proteinuria
aminonucleoside injection induced urea syndromes proteinuria
puromycin aminonucleoside injection induced urea syndromes nephrotic
puromycin aminonucleoside injection induced urea syndromes
aminonucleoside injection induced urea syndromes nephrotic
aminonucleoside injection induced urea syndromes
amikacin toxicity retinal
amikacin toxicity
amikacin treatment toxicity retinal
amikacin treatment toxicity
apomorphine Development induced behavior aggressive
apomorphine Development induced behavior
apomorphine induced behavior aggressive
apomorphine induced behavior
apomorphine treatment induced development behavior aggressive
apomorphine treatment induced development behavior
apomorphine treatment induced evidenced intensity aggressiveness
apomorphine induced behavior aggressive
apomorphine induced behavior
cisplatin observed limited dose e g nephrotoxicity ototoxicity
cisplatin associated toxicities dose e g nephrotoxicity ototoxicity
cisplatin observed limited dose e g nephrotoxicity
cisplatin associated toxicities dose e g nephrotoxicity
cisplatin trials suggested reduced incidence cisplatin induced nephrotoxicity ototoxicity
cisplatin induced nephrotoxicity ototoxicity
cisplatin trials suggested reduced incidence cisplatin induced nephrotoxicity
cisplatin induced nephrotoxicity
cisplatin trials suggested reduced incidence cisplatin induced nephrotoxicity neuropathy
cisplatin induced nephrotoxicity neuropathy
choline diet fed rats developed nodules carcinomas hepatocellular
choline diet fed rats developed nodules carcinomas
choline diet fed developed nodule carcinoma hepatocellular
choline diet fed developed nodule carcinoma
choline fed rats % carcinomas incidence hepatocellular
choline fed rats % carcinomas
choline containing diet fed rats fed rats % carcinomas incidence hepatocellular
choline containing diet fed rats fed rats % carcinomas
amitriptyline less incidence frequency vision mouth dry
amitriptyline less incidence frequency vision mouth
amitriptyline less incidence frequency vision blurred
amitriptyline less incidence frequency vision
propylthiouracil administration caused observations patient hepatitis chronic
propylthiouracil administration caused observations patient hepatitis active
propylthiouracil administration caused observations patient hepatitis active aggressive
propylthiouracil administration caused observations patient hepatitis
vigabatrin carbamazepine administration epilepsy absence
vigabatrin carbamazepine administration epilepsy
carbamazepine administration epilepsy absence
carbamazepine administration epilepsy
sodium nitroprusside anesthesia pressure maintenance system hypotension
nitroprusside anesthesia pressure maintenance system hypotension
SNP anesthesia pressure maintenance system hypotension
halothane anesthesia pressure maintenance system hypotension
SNP halothane effects hypotensive
halothane effects hypotensive
Antituberculosis therapy induced failure acute
Antituberculosis therapy induced failure liver
Antituberculosis therapy induced failure
Antituberculosis therapy failure acute
Antituberculosis therapy failure liver
Antituberculosis therapy failure
Antituberculosis therapy failure ATT ALF
Antituberculosis therapy failure ALF
fentanyl Omission reduce incidence nausea postoperative
fentanyl Omission reduce incidence nausea
fentanyl Omission reduce incidence nausea and
fentanyl Omission reduce incidence nausea vomiting
fentanyl % discharge moderate reduce did reduce incidence nausea postoperative
fentanyl % discharge moderate reduce did reduce incidence nausea
fentanyl % discharge moderate reduce did reduce incidence nausea and
fentanyl % discharge moderate reduce did reduce incidence nausea vomiting
fentanyl fentanyl % discharge moderate reduce did reduce incidence nausea postoperative
fentanyl fentanyl % discharge moderate reduce did reduce incidence nausea
fentanyl fentanyl % discharge moderate reduce did reduce incidence nausea and
fentanyl fentanyl % discharge moderate reduce did reduce incidence nausea vomiting
fentanyl groups Combining revealed reducing nausea postoperative
fentanyl groups Combining revealed reducing nausea
fentanyl groups Combining revealed reducing nausea and
fentanyl groups Combining revealed reducing nausea vomiting
Fentanyl reduce increased depression hypotension
Fentanyl reduce increased depression bradycardia
Fentanyl reduce increased respiratory
Fentanyl reduce increased depression
fentanyl exacerbated nausea postoperative
fentanyl exacerbated nausea
fentanyl exacerbated nausea and
fentanyl exacerbated nausea vomiting
heparin injection duration effect study bruising pain
heparin injection duration effect study bruising
heparin injection administration bruising pain
heparin injection administration bruising
heparin injection pain
heparin injection pain bruising prevent methods studied documented effect duration occurrence bruising pain
heparin injection pain bruising
heparin injection pain bruising prevent methods studied documented effect duration occurrence bruising
heparin bruising
heparin administration had effect bruising pain
heparin administration had effect bruising
iopamidol patients administration different nephropathy
iodixanol high iopamidol patients administration different nephropathy
